Stockwinners Market Radar for July 16, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
RL | Hot Stocks21:29 EDT Ralph Lauren responds to media reports in Indonesia - The company states: "Ralph Lauren notes recent media reports in Indonesia relating to disputes between PT Manggala Putra Perkasa, operating using the confusing "Polo Ralph Lauren Indonesia" name in Indonesia, and other parties in Indonesia. We would like to clarify that this company is not affiliated with or related to Ralph Lauren in any way and that these disputes do not involve Ralph Lauren. Ralph Lauren currently does not directly operate any stores in Indonesia, nor has it authorized or entered into an agreement with any partner or distributor to operate any "Polo Ralph Lauren" or other "Ralph Lauren" branded store in Indonesia. To address the demands of our customers in Indonesia, we have been selling our products only via certain third-party retailers. We are aware of several third parties, including PT Manggala Putra Perkasa, who have registered certain trademarks in Indonesia that are similar to Ralph Lauren's trademarks. PT Manggala Putra Perkasa has also set up a subsidiary that is named "PT Polo Ralph Lauren Indonesia". We recognize that these trademarks and names are a source of confusion. Ralph Lauren is committed to taking every necessary measure to ensure that its copyrights, trademarks and other intellectual property rights are not violated, as part of its efforts to provide authentic products and experiences to consumers in the region."
|
TKNO | Hot Stocks20:38 EDT Alpha Teknova CEO buys $100K in common stock - In a regulatory filing, Alpha Teknova disclosed that its CEO Stephen Gunstream bought 80.6K shares of common stock on July 12th in a total transaction size of $100K. Shares of Alpha Teknova were up 6% afterhours a $1.43.
|
OKLO | Hot Stocks20:02 EDT Cathie Wood's ARK Investment buys 214.5K shares of Oklo today
|
BNED | Hot Stocks19:28 EDT Barnes & Noble Education director buys $146.6K in common stock - In a regulatory filing, Barnes & Noble Education disclosed that its director Eric Singer bought 18K shares of common stock on July 16th in a total transaction size of $146.6K.
|
AFAR | Hot Stocks18:54 EDT Aura FAT Projects Acquisition enters into Trust Agreement - Aura FAT Projects Acquisition , a Cayman Islands exempted company limited by shares, entered into an Investment Management Trust Agreement, dated April 12, 2022 by and between the Company and Continental Stock Transfer & Trust Company, as trustee which was initially filed as an exhibit to the Company's Registration Statement on Form S-1 in connection with its initial public offering on April 18, 2022. On July 10, 2024, at 8:00 a.m. ET, the Company held a virtual extraordinary general meeting of its shareholders, pursuant to due notice ) in that certain Proxy Statement on Schedule 14(a) filed on June 21, 2024. At the Extraordinary General Meeting, the Company shareholders entitled to vote at the Extraordinary General Meeting cast their votes and approved the proposalto authorize the Company to enter into Amendment No. 2 to the Trust Agreement to amend the Trust Agreement to allow the Company to extend beyond July 18, 2024 the date by which either the Company must have completed its initial business combination or Continental must liquidate the Trust Account established in connection with the IPO. Following approval of the Trust Amendment Proposal by the Shareholders, the Company and Continental promptly entered into the Trust Agreement Amendment.
|
BHP | Hot Stocks18:41 EDT BHP Group guides FY25 copper output at 1,845-2,045 kt vs. 1,865 kt in FY24 - Guides FY25 iron ore output at 255-265.5 Mt vs. 259.7 Mt in FY24. Guides FY25 metallurgical coal output at 16.5-19.0 Mt vs. 22.3 Mt in FY24.
|
BHP | Hot Stocks18:37 EDT BHP Group reports Q4 copper output at 504.9kt, up 6% from last year - Reports Q4 iron ore output at 69.2Mt, up 6% from last year. Reports Q4 metallurgical coal output of 4.9Mt, down 42% from last year. CEO Mike Henry states: "We finished the year with a strong fourth quarter, achieving several production records and we are meeting current production and unit cost guidance for all commodities. WAIO continued its strong performance, delivering a second consecutive year of record production on the back of ongoing incremental improvements along its supply chain as we progress toward our medium-term goal of increasing production to greater than 305 Mtpa. We achieved a strong performance across our copper business globally, underpinned by the highest production in four years at Escondida and another year of record production from Spence in Chile. Successful integration at Copper South Australia has delivered additional production tonnes, and exceeded the annualised synergies planned at the time of the OZL acquisition. We successfully completed the sale of the Blackwater a d Daunia metallurgical coal operations on 2 April 2024. After a challenging year at BMA, we have plans in place to increase production to between 43 and 45 Mtpa (100%) in the next five years. We continued to execute against our strategy, progressing growth options in the commodities the world needs to meet the demands of the energy transition and population growth. This includes our Jansen potash mine in Canada, where construction of Stage 1 is now more than 50% complete and Stage 2 is underway. We will see first production in 2026 and will be a major global producer of potash by the end of the decade. On 11 July we announced the temporary suspension of our Western Australia Nickel operations from October 2024 as a result of an oversupply in the global nickel market and protracted low nickel prices."
|
CRWD | Hot Stocks18:32 EDT Crowdstrike exec Henry sells 4,000 class A shares - In a regulatory filing, Crowdstrike chief security officer Shawn Henry disclosed the sale of 4,000 class A common shares of the company on July 15 at a price of $371.32 per share.
|
PNFP | Hot Stocks18:08 EDT Pinnacle Financial reports Q2 net interest margin 3.14% vs. 3.20% last year
|
J | Hot Stocks17:39 EDT Jacobs files Form 10 with SEC for planned spin-off of business units - Jacobs has announced that a Form 10 has been publicly filed with the U.S. SEC for the previously announced planned spin-off of its Critical Mission Solutions and portions of its Divergent Solutions business, including the Cyber & Intelligence business. Filed under Amazon Holdco Inc., the Form 10 describes the spin-off and merger with Amentum Parent Holdings, to create a leading, publicly traded global engineering and technology solutions provider. The transaction is expected to close in the second half of the fourth quarter of fiscal year 2024. Upon closing, the combined company will be known as Amentum Holdings.
|
BA | Hot Stocks17:37 EDT Boeing provides NASA with second core stage of Space Launch System rocket - The company states: "Boeing has provided NASA with the second core stage of the Space Launch System (SLS) rocket. Built at NASA's Michoud Assembly Facility, the core stage is designed to send the Artemis II crew to lunar orbit for the first time in 50 years. The Boeing-built rocket stage, which is the largest component of the Artemis II mission, will be loaded onto the Pegasus barge and transported 900 miles to NASA's Kennedy Space Center. Once there, it will be integrated with the other Artemis II components, including the upper stage, solid rocket boosters, and NASA's Orion spacecraft inside the Vehicle Assembly Building. This integration is a crucial step in preparation for the Artemis II launch, scheduled for 2025. The delivery of Core Stage 2 signifies a major achievement in the development of the SLS rocket. This core stage, measuring over 200 feet tall and powered by four RS-25 engines, alongside two solid-fueled booster rockets, will provide the 8.8 million pounds of necessary thrust to propel Artemis II and future missions into space. SLS is the only rocket capable of carrying crew and large cargo to the moon and beyond in a single launch. Its unmatched capabilities will deliver human-rated spacecraft, habitats, and science missions to the moon, Mars and beyond."
|
BVN | Hot Stocks17:31 EDT Buenaventura reports Q2 total direct operated gold production 33.8K oz
|
GNRC | Hot Stocks17:26 EDT Generac announces availability of its first EV charger - Generac Power Systems announced the availability of its first electric vehicle, EV, charger. This state-of-the-art level 2 charger represents another notable solution in Generac's portfolio to help people with energy management, and underscores Generac's commitment to lead the evolution to more resilient, efficient, and sustainable energy solutions. With the United States' EV market share projected to reach over 11% in 2024 and more Americans wanting to use energy on their own terms, this is an ideal time for Generac to add a charging solution for homes and businesses."Generac's expansion into the EV charging market shows our dedication to advancement in energy management," said Kyle Raabe, executive vice president of Consumer Power at Generac. "With our extensive background in energy solutions and a network of nearly 9,000 certified North American dealers, we're poised to deliver an EV charging solution that sets a new standard for performance, reliability and user satisfaction." Reference Link
|
GTES ANF | Hot Stocks17:19 EDT Gates Industrial to replace Abercrombie & Fitch in S&P 600 at open on 7/22
|
ANF... | Hot Stocks17:18 EDT Abercrombie & Fitch to replace Equitrans Midstream in S&P 400 at open on 7/22 - S&P 500 constituent EQT Corp. (EQT) is acquiring Equitrans Midstream (ETRN) in a deal expected to close soon, pending final closing conditions.
|
VTNR | Hot Stocks17:05 EDT Vertex Energy updates operational targets for Q2 - Vertex Energy provided an update to its financial and operational outlook for the second quarter of 2024. Highlights include: expected reductions in direct operating expense of 7% and capital expenditures of 29%, compared to previous guidance midpoints; anticipated conventional throughput of 68,000 barrels per day, within guidance range of 68,000 to 72,000 bpd; and renewable throughput and utilization in line with prior guidance, which took into account the company's pause and pivot strategy. Benjamin Cowart, president and CEO of Vertex, stated, "We were in line with our guidance in the second quarter of 2024, coupled with continued lower operating expense and lower capital spending. We remain focused on margin improvement, reducing our costs and operating efficiently. We continue to execute on the strategic pause of our renewable diesel business and the pivot to producing conventional fuels from our hydrocracker unit."
|
WAFD | Hot Stocks17:03 EDT Washington Federal reports Q2 net interest margin 2.56% vs. 3.27% last year - Reports Q2 loan loss provision $1.5M vs. $9.0M last year.
|
ORIC... | Hot Stocks17:01 EDT Oric announces clinical collaborations with Bayer, Janssen - ORIC Pharmaceuticals (ORIC) announced it initiated dosing of ORIC-944, a potent and selective allosteric inhibitor of PRC2, in combination with darolutamide as well as in combination with apalutamide, in the first half of 2024 as part of the ongoing Phase 1b trial in patients with metastatic prostate cancer. Each combination cohort includes a dose escalation and expansion portion, evaluating the combination of ORIC-944 and NUBEQA or ORIC-944 and ERLEADA. The company also announced that it has entered into clinical trial collaboration and supply agreements with Bayer (BAYRY) and Janssen Research & Development, LLC, a Johnson & Johnson (JNJ) company, to evaluate ORIC-944 in combination with NUBEQA, Bayer's androgen receptor inhibitor, and ERLEADA, Johnson & Johnson's AR inhibitor. Under the terms of the collaborations, ORIC will continue to conduct and sponsor the ongoing Phase 1b trial, and Bayer and Johnson & Johnson will provide darolutamide and apalutamide, respectively, for the study. ORIC maintains full global development and commercial rights to ORIC-944. "We are pleased to enter into these clinical collaborations to investigate the broader potential of ORIC-944 in combination with AR inhibitors, a combination approach that we believe is particularly promising based on our preclinical findings as well as emerging clinical data," said Jacob M. Chacko, M.D., president and chief executive officer. "As reported at the AACR Annual Meeting earlier this year, the combination of ORIC-944 and AR inhibitors demonstrated synergy in multiple prostate cancer models with a unique mechanism of reprogramming prostate cancer to revert to an AR-dependent state. Together with the emerging clinical profile of ORIC-944, which has already demonstrated superior clinical half-life, robust target engagement and favorable safety as a monotherapy, the combination of ORIC-944 with an AR inhibitor has the potential to become a novel treatment paradigm for patients with prostate cancer."
|
DT | Hot Stocks16:59 EDT Dynatrace CRO Zugelder sells 15,404 common shares - In a regulatory filing, Dynatrace chief revenue officer Dan Zugelder disclosed the sale of 15,404 common shares of the company on July 15 at a price of $44.2182 per share.
|
NARI | Hot Stocks16:53 EDT Inari Medical's ThomasTu sells over $910K in company shares - Inari Medical's ThomasTu disclosed the sale of 16,520 shares of company stock for $55.09 per share on July 15, for a total transaction amount of $910,087.
|
APLM | Hot Stocks16:50 EDT Apollomics granted 180-day extension to regain Nasdaq bid price compliance - Apollomics announced that it received written notification from The Nasdaq Stock Market LLC that it has granted the company's request for a 180-day extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market. As previously disclosed, Apollomics had received a notice from Nasdaq on January 16, 2024 that it is not in compliance with the Bid Price Requirement, because the closing bid price of the company's Ordinary Shares was below $1.00 per share for 30 consecutive business days. Subject to the company meeting certain financial, share price and other requirements, Nasdaq granted the Company an extension until January 13, 2025 to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 the "Bid Price Requirement") for the Company's Class A ordinary shares, par value $0.0001 per share (the "Ordinary Shares"). If at any time before January 13, 2025 the closing bid price of the Company's Ordinary Shares is at least $1.00 per share for a minimum of ten consecutive business days, Nasdaq will provide written confirmation that the Company has achieved compliance with this minimum bid price requirement. If compliance with this minimum bid price requirement cannot be demonstrated to Nasdaq's satisfaction by January 13, 2025, Nasdaq will provide written notification that the Company's Common Stock will be delisted. At that time, the Company may appeal Nasdaq's delisting determination to a Nasdaq Hearings Panel.
|
BKNG | Hot Stocks16:43 EDT Booking Holdings CEO sells $3.05M in common stock - In a regulatory filing, Booking Holdings disclosed that its CEO Glenn Fogel sold 750 shares of common stock on July 15th in a total transaction size of $3.05M.
|
SAVE | Hot Stocks16:37 EDT Spirit Airlines down 5% after guidance cut, Cowen downgrade - Shares of Spirit Airlines are down 16c, or 5%, to $3.00 in after-hours trading.
|
FOXO | Hot Stocks16:37 EDT Foxo Technologies receives noncompliance notification from NYSE - Foxo Technologies reported that it has received an official notice of noncompliance from NYSE Regulation stating that the company is not in compliance with Section 1003 of the company guide since it reported stockholders' deficit of ($14.9M) as of March 31 and losses from continuing operations and/or net losses in its three most recent fiscal years ended December 31, 2023.
|
CPK | Hot Stocks16:34 EDT Chesapeake Utilities subsidiary receives approval in Florida for three projects - Chesapeake Utilities announced that its subsidiary, Peninsula Pipeline Company, or PPC, received approval from the Florida Public Service Commission for three projects that expand natural gas infrastructure to benefit customers of Florida City Gas, or FCG, also a subsidiary of Chesapeake Utilities. The projects, located in Florida's Brevard, Indian River and Miami-Dade counties, will bring renewable natural gas produced from local landfills into FCG's natural gas distribution system. The projects represent a combined capital investment of $46M and are estimated to be completed in the first half of 2025. In Brevard County, once completed, the project will reinforce FCG's system with a new alternative gas source, bringing additional supply of 3,200 Dth/day into the FCG distribution system. The Brevard County project will consist of approximately five miles of new transmission infrastructure with a total capital spend of approximately $6M. The new facilities will result in 3,200 Dth/day of additional supply into the FCG distribution system, providing resiliency to customers and consist of approximately 14 miles of new transmission infrastructure, a district regulator station, a tie-in with FCG's distribution system and an interconnect with existing PPC facilities. The total capital spend of the Indian River County project will be approximately $18M. The third project, in Miami-Dade County, will bring an additional 6,700 Dth/day of capacity to the area via approximately eight miles of new transmission infrastructure and a new district regulator station that is tied in with FCG's distribution system. The total capital spend of the project will be approximately $22M. In addition, the Florida Public Service Commission approved the transfer of the Pioneer Supply Pipeline asset from FCG to PPC, which allows Chesapeake Utilities to better align its assets and services within its relevant subsidiaries.
|
BE | Hot Stocks16:32 EDT Bloom Energy jumps 11% to $16.69 after announcing AI data center partnership
|
SHIM | Hot Stocks16:24 EDT Shimmick awarded $27.6M subcontract for Sunol Valley Water Plant ozonation - Shimmick Corporation announced that it has signed a $27,583,595 subcontract for electrical work on the Sunol Valley Water Treatment Plant Ozonation project. The prime contract, valued at $234,782,000, was awarded to J.F. Shea Construction, Inc. by the San Francisco Public Utilities Commission, SFPUC, on May 14. "We are thrilled to be part of this critical infrastructure project that will significantly improve water quality for millions of Bay Area residents," said Steve Richards, Chief Executive Officer. "This contract underscores our expertise in complex water treatment projects and our ability to perform critical specialized electric work that leverages our in-house capabilities." This project represents a significant investment in improving water quality for the San Francisco Bay Area. The ozonation system will provide additional primary disinfection, improve treatment reliability, and offer an extra barrier against potential emerging contaminants of concern.
|
SLCA APO | Hot Stocks16:22 EDT U.S. Silica's stockholders approve merger with Apollo Global - U.S. Silica Holdings (SLCA) announced that its previously announced agreement to be acquired by funds managed by affiliates of Apollo (APO) in an all-cash transaction, was approved at a special meeting of the Company's stockholders on July 16. The closing of the Merger remains subject to the terms and conditions of the agreement. Subject to such terms and conditions, the Company expects that closing of the Merger will occur before the end of the current quarter. Approximately 78% of the Company's outstanding shares were voted at the Special Meeting, and the Merger was approved by over 75% of the Company's outstanding shares.
|
RLAY RHHBY | Hot Stocks16:20 EDT Relay Therapeutics announces termination of license agreement with Genentech - In a regulatory filing, Relay Therapeutics (RLAY) announced that on July 11, the company received notice of termination of the Collaboration and License Agreement, dated December 11, 2020, as amended from time to time, with Genentech, Inc. (RHHBY) and F. Hoffmann-La Roche Ltd. Genentech elected to terminate the agreement without cause, and the termination will become effective 180 days after the date of receipt of the notice of termination. Under the agreement, the company and Genentech collaborate on the development and commercialization of RLY-1971, the company's oral, small molecule inhibitor of Src homology region 2 domain-containing phosphatase-2. Under the terms of the agreement, the company received aggregate consideration of $121.8M from Genentech, including $75M in an upfront payment, $45M in milestone payments as well as reimbursement of certain research and development costs. As a result of the termination of the agreement, the company will not be entitled to receive any further milestones or other payments due after the Termination Date. The parties will also cease to have any development or commercialization obligations after the Termination Date and the licenses the company granted to Genentech pursuant to the agreement will cease to be in effect as of the Termination Date.
|
AEHR | Hot Stocks16:17 EDT Aehr Test Systems to acquire Incal for $21M in cash and stock, sees accretion - Aehr Test Systems announced it entered into a stock purchase agreement to acquire all of the outstanding capital stock of Incal Technology, a Fremont, California-based, privately held manufacturer of packaged part reliability/burn-in test solutions used by a significant number of AI semiconductor manufacturers. Under the terms of the agreement, Aehr will acquire all the outstanding capital stock of Incal Technology, Inc. for a purchase price of $21M, consisting of $14 in cash and 552,355 shares of Aehr common stock at $12.673 per share, the average closing price of Aehr stock for the 10 trading days ending on the first trading day immediately preceding the date of the agreement, payable at closing and subject to certain post-closing adjustments with respect to working capital. For the period ended June 30, Incal recorded trailing 12-month revenue for test and burn-in systems, consumable burn-in boards and device electrical sockets and accessories of approximately $12. Aehr Test expects the acquisition to be immediately accretive. The transaction has been approved by the board of directors of both companies and is not subject to any financing condition. The acquisition is expected to close within the next 60 days.
|
AMZN | Hot Stocks16:16 EDT Amazon Prime Day a 'major cause of injuries' for workers, Senate probe finds - Amazon's Prime Day is a "major cause of injuries" for the warehouse workers who make it possible, a Senate probe found. As part of an ongoing investigation into Amazon's warehouse safety practices, Senator Bernie Sanders, Chairman of the Senate Committee on Health, Education, Labor, and Pensions released an interim report on the "extremely unsafe conditions" in Amazon warehouses during Prime Day and the holiday season and called on the company to do more to protect warehouse workers. This interim report shed light on Amazon workers' experiences during Prime Day and the holiday season. It also makes public, for the first time, the company's internal data on warehouse injury rates, which reveal just how dangerous its warehouses are during peak seasons. According to the internal data, during Prime Day 2019, Amazon's rate of recordable injuries-the injuries Amazon is required to disclose to the Occupational Safety and Health Administration-was over 10 injuries per 100 workers. "During that same period, Amazon's total injury rate, which includes injuries Amazon is not required to disclose to OSHA, was just under 45 injuries per 100 workers. That is nearly half of the company's warehouse workers. These injury rates are especially egregious in light of the incredible revenue the company generates and the resources it has available to make its warehouses safe for workers." The report also accused Amazon of prioritizing speed over safety, saying it pressured employees to work long hours and shirked some safety procedures. "This is not an acceptable set of practices from one of the richest companies in the world. Amazon must address its injury crisis and ensure that all workers are safe at their jobs, especially during the most intense and demanding periods." Reference Link
|
AEHR | Hot Stocks16:14 EDT Aehr Test Systems receives $12.7M in orders for WaferPak full wafer contactors - Aehr Test Systems announced it has received $12.7M in orders from one of its silicon carbide test and burn-in customers for multiple sets of WaferPak full wafer contactors to be used for production needs for wafer level burn-in and screening of silicon carbide power semiconductors for the electric vehicle market. These WaferPaks are expected to be delivered over the next three months.
|
UFPT | Hot Stocks16:14 EDT UFP Technologies acquires Marble Medical, no terms - UFP Technologies announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along with their precision die cutting capabilities, gives our clients access to a broader range of innovative solutions incorporating highly specialized adhesive technologies." "In addition, Marble Medical is a longstanding partner to our DAS Medical operation, making them an excellent overall fit into our MedTech business," continued Bailly. "This acquisition aligns with our strategic focus and provides valuable technologies in multiple key markets to bring more value to our client base. This expanded range of materials and capabilities will also allow us to vertically integrate in many existing application areas. Joe Audie, Marble Medical's president, stated, "We are excited to join the UFP family and be part of such a fast growing and dynamic company. UFP's customer base, engineering skills, vast resources, and global manufacturing footprint is expected to help Marble accelerate growth by leveraging our biocompatible adhesives expertise in adjacent areas such as diagnostic patches, wound care, and other stick to skin applications."
|
JBHT | Hot Stocks16:13 EDT J.B. Hunt down 3% at $171.07 after below-consensus Q2 results
|
HWC | Hot Stocks16:12 EDT Hancock Whitney reports Q2 net interest margin 3.37% vs. 3.30% last year - Reports Q2 loan loan provision $8.7M vs. $7.6M last year. Reports Q2 ROA 1.32% vs. 1.30% last year. Q2 CET1 ratio estimated at 13.25%, up 60 bps linked-quarter.
|
ACRS LLY | Hot Stocks16:12 EDT Aclaris sells portion of OLUMIANT royalties to Omers for $26.5M upfront - Aclaris Therapeutics (ACRS) announced the sale of a portion of Aclaris' future royalty payments and certain milestones from Eli Lilly (LLY) on net sales of OLUMIANT or baricitinib, for the treatment of alopecia areata to OMERS, one of Canada's largest defined benefit pension plans. Under the terms of the agreement, Aclaris has received an upfront payment of $26.5M, and is eligible to receive up to an additional $5M based on the achievement of certain sales milestones for OLUMIANT in 2024. In exchange, OMERS has acquired a portion of the royalty paid by Lilly to Aclaris for worldwide net sales of OLUMIANT for alopecia areata from April 1 through the remainder of the royalty term under Aclaris' license agreement with Lilly, and 100% of the remainin anniversary milestone payments payable by Lilly to Aclaris under the license agreement. "This transaction bolsters our balance sheet and provides us with enhanced financial flexibility to pursue a range of value-creating opportunities while continuing to invest in our internal programs," said Dr. Neal Walker, Interim President & CEO and Chair of the Board of Directors of Aclaris. "As we progress with our strategic review, we will continue to pursue available opportunities to enable us to invest in programs that complement and enhance our existing drug development pipeline." OLUMIANT is a registered trademark of Eli Lilly and Company.
|
PRIM | Hot Stocks16:11 EDT Primoris receives project awards valued at roughly $1.2B - Primoris Services Corporation announced several awards with a combined value of approximately $1.2B secured by the company's Energy Segment. The awards include nearly $700M contracted in the second quarter of 2024 and more than $500M booked early in the third quarter of 2024. The projects consist of $1.1B for the engineering, procurement and construction of utility-scale solar projects and around $100M for the expansion of multiple combustion gas turbine generators. "We continue to see strong demand in our utility-scale solar and natural gas generation solutions driven by a growing need for power generation and the strength of our customer relationships that value our track record of safely and successfully executing their projects," said Tom McCormick, President and Chief Executive Officer of Primoris. "The solar awards, which include approximately 800 MWh of battery energy storage systems, demonstrate progress toward our strategic goal to expand our solar service offering and provide a comprehensive solution for our clients." The projects are scheduled to begin mobilization in the second half of 2024 through the second quarter of 2025.
|
BE | Hot Stocks16:08 EDT Bloom Energy, CoreWeave to partner on AI data center power solutions - The company states: "Bloom Energy announced a strategic partnership with CoreWeave, Inc. This win underscores Bloom's ability to meet the rising energy demands of the rapidly growing AI sector. Bloom will deploy its proprietary fuel cells to generate on-site power for CoreWeave at a high-performance data center owned by Chirisa Technology Parks located in Volo, Illinois. The modern data center will allow for high-density deployments with advanced cooling systems, allowing CoreWeave to offer performant and efficient cloud solutions for AI. Bloom's fuel cells are set to be commissioned in Q3 2025."
|
HRTG | Hot Stocks16:07 EDT Heritage Insurance rejoins Russell 3000 Index - Heritage Insurance Holdings announced its inclusion in the Russell 3000 Index, as confirmed by the reconstitution information posted on the FTSE Russell website. The inclusion into the index took effect at the opening of the U.S. equity markets on Monday July 1.
|
FTK | Hot Stocks16:05 EDT Flotek subsidiary announces EPA approval for JP3 system - Flotek Industries' wholly owned subsidiary JP3 Measurement, a leader in innovative analytical measurement solutions, announced that the Environmental Protection Agency, or EPA, has designated the JP3 system as an approved measurement technology with respect to recently enacted flare regulations. This state-of-the-art optical instrument, designed for the precise measurement of net heating values, or NHV, in flare gases, is the first to be approved as an alternative method under the new NSPS OOOOb regulations, supporting cleaner and more efficient operations across the oil and gas industry. JP3's technology utilizes advanced Near InfraRed Spectroscopy to deliver accurate, autonomous, and continuous real-time flare emission measurements. Its robust design is specifically engineered for challenging field conditions typical of midstream and upstream sectors, simplifying complex compliance hurdles.
|
PRI | Hot Stocks16:04 EDT Primerica to exit Senior Health business - The company states: "Primerica announced that after carefully considering various options, the Board of Directors has opted to exit its senior health business by relinquishing ownership of e-TeleQuote Insurance, Inc. (e-TeleQuote). The senior health subsidiary, acquired in July 2021, does not have a clear path toward anticipated profitability within an acceptable timeframe in the increasingly challenging senior health distribution market. Further, the industry is facing an uncertain regulatory environment that could adversely impact the business. The Board and management recognize that there remains significant demand for senior healthcare due to the aging of the U.S. population and continues to believe that Primerica's unique ability to reach middle-income families through its independent sales force is a clear competitive advantage. However, Primerica's ownership of a senior health business has not created the near-term stockholder value that had been anticipated at the time of the acquisition of e-TeleQuote. With the assistance of a third-party consultant specializing in turn-around and restructuring transactions, Primerica determined that relinquishing its ownership of e-TeleQuote is the most expeditious way to exit its senior health business while maximizing Primerica's residual stockholder value. Primerica expects to terminate its rights to e-TeleQuote no later than September 30, 2024. On or prior to such time, e-TeleQuote expects to issue shares of its common stock to a third party who has not yet been identified. It is expected that such third party, which may consist of one or more entities, will ultimately own e-TeleQuote when Primerica terminates its rights."
|
FIVE | Hot Stocks16:03 EDT Five Below CEO Joel Anderson steps down, Kenneth Bull named interim CEO - Five Below announced the appointment of Kenneth Bull as interim president and CEO, effective immediately. Joel Anderson has stepped down from his roles of president and CEO, and from the board of directors, to pursue other interests. Thomas Vellios, co-founder, non-executive chairman and former CEO, is assuming the role of executive chairman on an interim basis to support Bull and the executive leadership team in the transition while the board conducts a search for a permanent CEO.
|
UFPT | Hot Stocks16:03 EDT UFP Technologies acquires thermoforming firm Welch Fluorocarbon, no terms - UFP Technologies announced the acquisition of Welch Fluorocarbon. Founded in 1985 and headquartered in Dover, New Hampshire, Welch Fluorocarbon develops and manufactures thermoformed, and heat sealed implantable medical device components utilizing thin, high-performance films. "Welch Fluorocarbon will bring significant thin film thermoforming capabilities to our expanding MedTech portfolio of technologies and materials," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Their expertise in developing and manufacturing components for implantable medical devices is an excellent complement to our existing thin film platform." "UFP and Welch Fluorocarbon share many clients and together, our expanded product development and manufacturing capabilities will allow us to serve our clients in a more comprehensive way," continued Bailly. "Additionally, we are gaining a talented leadership team and overall, the Welch Fluorocarbon team is a very strong cultural fit."
|
PSN BAESY | Hot Stocks15:04 EDT Parsons awarded $15.4M contract by BAE Systems - BAE Systems (BAESY) has selected Parsons (PSN) to begin initial designs for the modernization of the Alternate Nitrate Ester Manufacturing Facility at the Radford Army Ammunition Plant. Under this two-year, $15.4M contract, Parsons will prepare a series of preliminary design packages for the RFAAP manufacturing facility.
|
PARA | Hot Stocks14:31 EDT Paramount expands partnership with Ice Cube and Cube Vision, no terms - Paramount Global announced an expanded partnership with Ice Cube and his production company Cube Vision on the heels of their long standing relationship. Under the first look deal for television, Cube and Jeff Kwatinetz, COO of Cube Vision and Cube's producing partner, will develop and executive produce projects for broadcast, cable and streaming platforms across Paramount. The deal kicks off with a new untitled scripted project in development at SHOWTIME Studios that explores the cutthroat world of Hollywood through the Black experience and the depths an explosive cast of characters go in pursuit of power and the price of fame. The expanded partnership stems from the company's long-standing relationship with Cube where the parties work together on Big3 basketball league that airs on CBS, Hip Hop Squares for VH1 alongside many music related projects over the years and a featured role in Teenage Mutant Ninja Turtles: Mutant Mayhem, where Cube voiced/starred in the Seth Rogan co-written film. "We are excited to expand on our successful partnership with Paramount through this unique television deal," said Ice Cube & Jeff Kwatinetz. "This deal provides us with everything we need to bring amazing and authentic stories to television working with the best writers, showrunners, and television innovators in the entire business. We are thrilled to collaborate with Nina, Chris, and the rest of the All-Star Paramount Global team to build upon the great work we've done together."
|
SMG | Hot Stocks13:47 EDT Scotts Miracle-Gro trading resumes
|
SMG | Hot Stocks13:24 EDT Scotts Miracle-Gro trading halted, news pending
|
BZFD | Hot Stocks13:08 EDT BuzzFeed up 12% after Pulte tweet says activist position taken - BuzzFeed shares are up 35c, or 12%, to $3.16 following a tweet earlier that stated: "The Pulte Family, the founding family of Fortune 500 PulteGroup Inc, has taken an activist position in BuzzFeed. In our opinion, the Current BuzzFeed CEO Jonah Peretti is driving the company into the ground, and when Vivek Ramaswamy gave him a life boat to save his sinking ship, Peretti told him thanks anyway. This is exactly the type of hubris that needs to end in corporate America; at every turn, CEO Peretti has delivered unacceptable financial and operational performance, quarter after quarter. If CEO Peretti isn't up to modernize BuzzFeed, then he should bring in someone who is or he should buy the company back from its shareholders. We support the changes Vivek Ramaswamy has proposed and that which he thinks are necessary," said William J. Pulte, CEO of Pulte Capital and a former Director of PulteGroup." Pulte furthered, "For the avoidance of doubt, we are not working in concert with and are not working in a group with Mr. Ramaswamy. To that end, we did not inform Mr. Ramaswamy before we purchased shares in BuzzFeed." Reference Link
|
PEP YARIY | Hot Stocks12:12 EDT Yara to supply PepsiCo Europe with fertilizer to cut food emissions - PepsiCo Europe (PEP) and Yara (YARIY) earlier today announced a long-term partnership in Europe aimed at providing farmers with crop nutrition programs to help decarbonize the food value chain. As part of the partnership, which spans multiple countries, participating PepsiCo Europe farmers will be equipped with crop nutrition products and advice as well as precision farming digital tools. "This will allow them to increase nutrient use efficiency, boost yields and reduce the carbon footprint of their crops. Yara, the leading crop nutrition company in Europe, will supply PepsiCo with the products and services," the companies said in a statement. Yara will deliver up to 165,000 tons of fertilizer per year to PepsiCo, covering around 25% of their crop fertilizer needs in Europe by 2030. Reference Link
|
SGH | Hot Stocks12:02 EDT SMART Global Holdings to rebrand as Penguin Solutions - SMART Global Holdings announced its intention to become Penguin Solutions. The company said, "This rebranding is a continuation of the company's transformation over the past several years and reflects its focus on delivering leading-edge solutions that solve the complexity of AI. The new Penguin Solutions is uniquely positioned as an expert in end-to-end AI infrastructure solutions." SGH is expected to complete its transition to Penguin Solutions later this year subject to shareholder approval. The Cree LED brand, also a business unit of SGH, will remain unchanged and will continue to do business as Cree LED.
|
AMWL | Hot Stocks12:01 EDT Amwell rises 11.4% - Amwell is up 11.4%, or 85c to $8.30.
|
HMY | Hot Stocks12:01 EDT Harmony Gold rises 16.0% - Harmony Gold is up 16.0%, or $1.51 to $10.96.
|
EB | Hot Stocks12:01 EDT Eventbrite rises 20.7% - Eventbrite is up 20.7%, or 96c to $5.60.
|
RDW | Hot Stocks12:01 EDT Redwire falls -6.3% - Redwire is down -6.3%, or -51c to $7.58.
|
RDDT | Hot Stocks12:00 EDT Reddit falls -7.3% - Reddit is down -7.3%, or -$5.31 to $67.67.
|
SCHW | Hot Stocks12:00 EDT Charles Schwab falls -8.9% - Charles Schwab is down -8.9%, or -$6.68 to $68.39.
|
SPRC | Hot Stocks11:56 EDT SciSparc announces receipt of Nasdaq minimum bid price notification - SciSparc Ltd. announced it has received a written notice from Nasdaq Stock Market LLC indicating that the company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), the company has been granted a period of 180 calendar days to regain compliance with the minimum bid price requirement. The Notice has no immediate effect on the company's Nasdaq listing or the trading of its ordinary shares, and during the grace period, as may be extended, the company's ordinary shares will continue to trade on Nasdaq under the symbol "SPRC". According to the Notice, the company has until January 13, 2025, to regain compliance with the minimum bid price requirement.
|
TRP | Hot Stocks11:43 EDT TC Energy 'disappointed' in Tribunal ruling that NAFTA claim cannot proceed - In a media statement, TC Energy said the company "is disappointed that the Tribunal hearing the company's claim to recover more than US$15 billion in damages resulting from the revocation on Jan. 20, 2021 of the Presidential Permit for the Keystone XL Project has determined in a jurisdictional ruling that the claim cannot proceed." Patrick Keys, Executive Vice-President and General Counsel, TC Energy, said: "We are both disappointed and frustrated with the Tribunal's decision to deny our right to bring a legacy NAFTA claim. This ruling does not align with our expectations and views of the plain interpretation of the protections NAFTA and the USMCA were designed to offer. TC Energy was treated unfairly and inequitably in the revocation of the Permit, which was driven by political considerations." The company added: "TC Energy has not recognized in its financial statements, nor factored into its outlook, any potential recoveries related to the NAFTA claim." Reference Link
|
STT | Hot Stocks11:23 EDT State Street sees positive fee operating leverage, operating leverage for FY
|
STT | Hot Stocks11:22 EDT State Street sees 2024 NII to be up slightly y/y vs. previous view down 5% y/y - Sees full year expenses somewhat higher than previous outlook.
|
STT | Hot Stocks11:22 EDT State Street sees total fee revenue up 4%-5% on FY basis
|
TROW | Hot Stocks11:17 EDT Oak Hill Advisors, OneIM partner to invest in European private credit - Oak Hill Advisors and One Investment Management announced the formation of a partnership to invest in European private credit. The new venture has initially up to $5B of investable capital which will help address the needs of European borrowers. Both firms will benefit from the partnership's size and scale, as well as the teams' combined sourcing and origination capabilities.
|
MMM | Hot Stocks11:14 EDT 3M invests in green hydrogen company Ohmium - 3M has completed a strategic investment in Ohmium International, a developer of electrolyzer systems for green hydrogen production. The investment is part of 3M's commitment to advancing technologies that support the transition to a low-carbon economy and may help the company explore further decarbonizing its own operations. The investment aligns with 3M's strategic growth platform in climate tech and its vision to leverage 3M's deep technological expertise in material science in support of the Department of Energy's "Hydrogen Energy Earthshot" and the industry goal of reducing the cost of green hydrogen production to $1 per kilogram. Ohmium is known for the efficiency of its Proton Exchange Membrane electrolyzers, designed to optimize PEM's industry leading performance in pairing with renewables to produce green hydrogen. Green hydrogen is a fossil-free energy source critical for decarbonizing hard to abate industrial sectors such as steel manufacturing and fertilizer production. Ohmium's proprietary power electronics, hyper-modular design and standardized manufacturing approach have positioned the company as a leader in cost-competitive, efficient and high-output green hydrogen production.
|
STT | Hot Stocks11:09 EDT State Street on track to achieve 2024 servicing fee sales goal of $350M-$400M - Comments taken from Q2 earnings conference call.
|
EB | Hot Stocks11:04 EDT TikTok announces partnership with Eventbrite - In a post to its corporate newsroom, TikTok stated: "Today, TikTok is excited to announce a partnership with the global events marketplace Eventbrite, offering event creators a powerful new way to promote their events and sell tickets across a wide range of categories. The new partnership will also enable the global TikTok community to sell tickets to their own events. Now, any Eventbrite creator or TikTok user can add Eventbrite links directly to their TikTok videos, helping the TikTok community discover event details and purchase tickets without ever leaving the app. Through this partnership, any TikTok user can easily become an event creator by hosting their events on Eventbrite, and seamlessly promoting and selling tickets directly to the TikTok community... The new feature is available in all countries where both TikTok and Eventbrite services are available. Eligible events must be in-person, publicly listed on Eventbrite, have paid tickets, and occur within the next 90 days (or 180 days for music events)." Reference Link
|
SCHW | Hot Stocks10:48 EDT Schwab drops 7% after speaking of 'smaller bank' on earnings call - The shares are down 7%, or $5.31, to $69.79 in morning trading following Charles Schwab's Q2 report and earnings call.
|
SCHW | Hot Stocks10:47 EDT Charles Schwab says various actions to lead to 'somewhat smaller' bank - Says "somewhat smaller" bank will help meet clients' banking needs, lower the bank's capital intensity and protect the economics it is able to generate from owning a bank. Comments taken from Q2 earnings conference call.
|
PNC | Hot Stocks10:21 EDT PNC Financial says remains diligent in continuous improvement efforts - Says well-positioned for second half of the year. Says expect the Fed to cut rates two times in 2024.
|
PRDO | Hot Stocks10:12 EDT Perdoceo Education signs agreement to acquire USAHS - Perdoceo Education Corporation, a provider of postsecondary education, reported that it has signed a definitive agreement to acquire 100% ownership of the University of St. Augustine for Health Sciences, LLC. Completion of the acquisition is subject to customary closing conditions and satisfactory regulatory approvals from the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges, as well as other key regulatory bodies, and receipt of a preacquisition review response from the US Department of Education. The company expects to complete the acquisition in December 2024. The ownership transition is not expected to impact the current academic programs of USAHS, and USAHS will remain fully committed to serving and educating students and providing the same high quality educational experience. Perdoceo expects to pay approximately $142M-$144M in cash at closing to acquire 100% ownership of USAHS. The actual cash paid will depend on adjustments for cash, debt and working capital based on the final closing balance sheet. Pursuant to the merger agreement, Perdoceo has purchased a buyer-side representation and warranty insurance policy, which will serve as the primary source of protection against certain risks associated with representations and warranties made by the seller and pre-closing tax liabilities. The boards of directors of both parties to the merger, the USAHS board of directors, and the USAHS stockholders holding 100% of the voting power over USAHS' parent's outstanding common stock, each have unanimously approved the acquisition. The acquisition is not subject to a financing condition. Perdoceo plans to use cash on hand for the purchase.
|
MS | Hot Stocks10:10 EDT Morgan Stanley CEO sees normal M&A returning unless full-blown recession
|
PNC | Hot Stocks10:10 EDT PNC Financial says remains well-capitalized - Says on a growth trajectory to expected 'record' NII in 2025. Says expense discipline remains a top priority. Says credit quality remains relatively stable. Says well-positioned to drive further growth into 2025. Says continues to be well-positioned with capital flexibility. Comments taken from Q2 earnings conference call.
|
HMY | Hot Stocks10:01 EDT Harmony Gold rises 7.7% - Harmony Gold is up 7.7%, or 72c to $10.18.
|
UP | Hot Stocks10:01 EDT Wheels Up rises 10.0% - Wheels Up is up 10.0%, or 36c to $3.97.
|
CHGG | Hot Stocks10:01 EDT Chegg rises 15.0% - Chegg is up 15.0%, or 47c to $3.65.
|
MSC | Hot Stocks10:00 EDT Studio City falls -4.3% - Studio City is down -4.3%, or -30c to $6.67.
|
RDDT | Hot Stocks10:00 EDT Reddit falls -4.4% - Reddit is down -4.4%, or -$3.23 to $69.75.
|
SCHW | Hot Stocks10:00 EDT Charles Schwab falls -6.4% - Charles Schwab is down -6.4%, or -$4.79 to $70.28.
|
MS | Hot Stocks09:56 EDT Morgan Stanley sees inflection in NII over next year
|
MS | Hot Stocks09:51 EDT Morgan Stanley CFO says entering back half of year in position of strength
|
MS | Hot Stocks09:48 EDT Morgan Stanley CFO sees NII declining modestly in Q3 - Says NII could inflect higher into next year.
|
MSC | Hot Stocks09:47 EDT Studio City falls -4.3% - Studio City is down -4.3%, or -30c to $6.67.
|
RDDT | Hot Stocks09:47 EDT Reddit falls -4.7% - Reddit is down -4.7%, or -$3.42 to $69.56.
|
SCHW | Hot Stocks09:47 EDT Charles Schwab falls -6.3% - Charles Schwab is down -6.3%, or -$4.76 to $70.31.
|
ANVS | Hot Stocks09:47 EDT Annovis Bio rises 6.2% - Annovis Bio is up 6.2%, or 79c to $13.43.
|
SHOP | Hot Stocks09:47 EDT Shopify rises 6.2% - Shopify is up 6.2%, or $3.95 to $68.16.
|
CHGG | Hot Stocks09:47 EDT Chegg rises 12.0% - Chegg is up 12.0%, or 38c to $3.55.
|
BAC | Hot Stocks09:46 EDT Bank of America expects deposits to grow over time after peak Fed Funds rate - Says deposit growth "doing ok so far." Expects three 25 bps rate cuts in 2024, starting in September. Expects to make "meaningful strides" in NII trajectory in 2025. "Feels good" about how the company is managing expenses.
|
MS | Hot Stocks09:41 EDT Morgan Stanley CFO says IB investments paying off as capital markets improve - Says in early innings of investment bank rebound.
|
LPA | Hot Stocks09:40 EDT Logistic Properties of The Americas trading resumes
|
DCI | Hot Stocks09:40 EDT Donaldson expands relationship with Gene Therapy Program at UPenn - Donaldson announces that the Gene Therapy Program at the University of Pennsylvania is expanding its evaluation agreement aimed at determining the scalability of GTP's gene therapy product manufacturing using Univercells Technologies' bioreactors. GTP is an academic program focused on genetic medicines led by James M. Wilson, MD, PhD, the Rose H. Weiss Professor and Director of the Orphan Disease Center and a professor of Medicine and Pediatrics at the Perelman School of Medicine. GTP seeks to make gene therapies for rare diseases accessible worldwide. This agreement covers GTP's evaluation of the commercial- series scale-X nitro 600 m2 bioreactor, with the goal of substantially increasing production per batch and potentially reducing cost of goods sold. This important work between GTP and Univercells Technologies underscores the importance of industry-academic partnerships in advancing the field of gene therapy and accelerating the development and commercialization of life-changing treatments for patients worldwide.
|
LPA | Hot Stocks09:35 EDT Logistic Properties of The Americas trading halted, volatility trading pause
|
MS | Hot Stocks09:34 EDT Morgan Stanley CEO: 'We're back' in institutional securities - Comments taken from Q2 earnings conference call.
|
MULN GM | Hot Stocks09:33 EDT Mullen Automotive's Bollinger Motors appoints James Taylor as CEO - Bollinger Motors (MULN) announces it has named former GM (GM) executive James Taylor as CEO. He will take over for company founder Robert Bollinger, who will remain on the company's Board of Directors and a major shareholder. In addition, the company promoted Bryan Chambers to President and COO and Siva Kumar to Chief Strategy Officer and Senior Vice President of Finance.Taylor has worked closely with Robert Bollinger to bring the company's all-electric Bollinger B4 Class 4 Chassis Cab to market. Taylor is a veteran automotive executive who has held leadership positions with Cadillac and Hummer, and has deep electric vehicle experience with Electric Last Mile Solutions, Workhorse, Karma, SF Motors and Mullen Automotive for the last two years. Chambers has over 35 years in automotive leadership and joined Bollinger Motors in 2018 as Program Director and rose to COO. Kumar joined Bollinger Motors in 2022 as CFO.
|
TEM | Hot Stocks09:31 EDT Tempus AI launches AI-enabled, multimodal immune profile algorithmic tests - Tempus AI announced that its multimodal immune profile score algorithmic test is now available for research use only. IPS is the first offering of a larger immunotherapy-based portfolio being developed at Tempus to bring next-generation algorithmic diagnostics to the immuno-oncology space. Additionally, Tempus is collaborating with other partners, like Cleveland Clinic, to bring additional immunotherapy-focused algorithmic tests to this growing portfolio, leveraging clinical, laboratory, genomic, and transcriptomic data to identify patients that may respond to immunotherapy. Tempus' IPS is a pan-cancer, laboratory developed test that assesses a combination of immunotherapy-related biomarkers from prior DNA and RNA test results to calculate an IPS from 0-100 and a classification of either IPS-Low or IPS-High. IPS results can support patient stratification across pan-cancer cohorts to help inform who may or may not respond to immunotherapy. The IPS test is available today to life sciences partners for research use only, and is intended to be available as an add-on option for clinicians ordering Tempus' xT and xR at the end of the year. Tempus is performing a retrospective, real-world study to evaluate the prognostic and the predictive utility of IPS in advanced pan-cancer patients treated with immune checkpoint inhibitors and will be releasing data later this year. In addition to developing and launching IPS, Tempus has licensed a machine-learning-based algorithmic test developed by Timothy A. Chan, MD, PhD, Cleveland Clinic. As described in Nature Biotechnology, the test demonstrates an ability to predict the efficacy of immune checkpoint blockade based on patient-specific biological, laboratory, genomic, and clinical factors, and adds to our expanding immunotherapy specific biomarker portfolio.
|
PSHG | Hot Stocks09:30 EDT Performance Shipping secures sale, leaseback agreement for Aframax tanker - Performance Shipping announced that, through a separate wholly-owned subsidiary, it has entered into a sale and leaseback agreement with an unaffiliated Japanese third party for a previously announced newbuild LR2 Aframax tanker vessel. As announced on March 8, 2023, the newbuilding LNG-ready, scrubber-fitted, Tier III LR2 Vessel of approximately 114,000 dwt is expected to be delivered to the Company in the fourth quarter of 2025. The bareboat financing amount totals $44.25 million and as part of this agreement, the Vessel will be sold and chartered back on a bareboat basis for an eight-year period from delivery at bareboat charter rates equivalent to 96 monthly installments of $7,132 per day and a balloon payment of approximately $23.7 million payable together with the last installment, with an implied interest rate of Term SOFR plus 2.425% per annum. The Company has continuous options to repurchase the Vessel at predetermined rates following the second anniversary of the bareboat charter. As previously announced on March 12, 2024, the Vessel has been chartered to Clearlake Shipping Pte Ltd. for a period of five years, upon delivery of the Vessel, at a rate of $31,000 per day and an option to extend for a 6th and 7th year at a base rate plus profit sharing if declared by the charterer.
|
LEXX | Hot Stocks09:26 EDT Lexaria Bioscience appoints Nelson Cabatuan as chief strategic financial advisor - Lexaria Bioscience announces plans for strategic growth. Lexaria will be expanding its management team this summer as it prepares for the greater workload of multiple projects and initiatives. The first step is appointing Nelson Cabatuan as our consulting Chief Strategic Financial Advisor, in order to maximize his skills in the fields of corporate finance and strategic industry relationships and opportunities. Nelson is resigning from his current role as CFO in order to better focus on the strategic opportunities afforded to the Company outside of typical accounting tasks. Our new CFO will be appointed and announced in due course. The Company is also in the conceptual design stages of additional R&D projects related to additional GLP-1 molecules of interest, beyond those previously disclosed. Announcements about additional R&D studies may be made over the next several months. Finally, Lexaria is closely examining its Phase 1b hypertension study, that has already received clearance to proceed from the FDA, for more concrete steps to launch that study, subject to funding, as soon as possible.
|
MTWO | Hot Stocks09:23 EDT M2i Global executes exclusive offtake agreement with NT Minerals - M2i Global has entered into an exclusive offtake agreement with NT Minerals for 88,000 tonnes of Copper, which is currently valued at $850 million based on today's price of $9,653 per ton of Copper. M2i is granted offtake rights for a maximum of 88,000 tonnes copper that is sourced from the Redbank tenements in return for 12 million shares of M2i Global Inc. NTM to receive additional payments for incremental resource increases or upgrades from the Redbank tenements. M2i retains the option to participate in production pre-funding opportunities. NTM's initial area of interest is centered on the Bluff Resource, notably a cluster of targets within a 600 meter radius of the Bluff deposit, these being Double Bluff, gravity targets - T24, T25 and T27 and Archimedes Targets - AT2 and AT4. Each of these targets have varying levels of support from each of the target generation concepts providing the Company confidence to undertake the planned drill program. NTM considers this clustering of targets important as any future development may be potentially accessed from the same infrastructure. Additionally, a 1,700 m long linear copper geochemical trend has been identified northeast of Bluff, this trend is defined by the RN North geochemical anomaly at its northern extent and the T25 gravity/geochemical anomaly at its southern extent, with potential to extend this anomaly in both directions. Importantly, this trend also includes the Quartzite Prospect, located some 650m WNW of Bluff and the subject of limited historical drill evaluation with a best reported intercept of 52m @ 1.34% Cu from 119m, including 8m @ 3.98% Cu from 163min drill hole QT35. The Company intends to investigate this trend, targeting the 500m long RN_North anomaly, Quartzite Prospect and the T25 gravity target with reconnaissance drill programs. Regionally, NTM also plans to undertake regional reconnaissance work during the 2024 field season across several areas identified by previous explorers but that have not been fully evaluated since the original work. This includes the Mountain Home Prospect located in the Redbank West group of tenements where a recent geological review noted rock chip sampling along a 150m trend of surface workings/pittings returned assays of 32.73% Cu, 25.20% Cu, 15.69% Cu and 9.81% Cu with associated gold values up to 1.31 g/t Au. This highly mineralized trend is coincident with an interpreted +5km long structure warranting further investigation. Other areas being targeted for regional reconnaissance work include Copperado, Wollogorang and Siegal Gap. NTM is well advanced in progressing the requisite approvals for the various programs and has received expressions of interest and pricing from several well credentialed drilling contractors to undertake the planned programs. The commencement of the 2024 field season is currently scheduled for early July and is dependent on access after a very significant wet season.
|
UNH | Hot Stocks09:20 EDT UnitedHealth says expects balanced pacing in the second half - Says enters second half of the year with momentum. Says reiterated FY24 adjusted EPS outlook despite business disruption impact from cyberattack. Says expects balanced pacing in the second half. Says navigated complex external environment. Says a couple of areas of pressure at the margin. Comments taken from Q2 earnings conference call.
|
VRTX | Hot Stocks09:17 EDT Vertex Pharmaceuticals expands drug discovery collaboration with Genomics - Vertex Pharmaceuticals announced a three-year extension of its collaboration with healthcare company Genomics to use human genetics and machine learning to improve the discovery and development of new precision medicines. The partnership, which began in 2018, was previously extended in 2021. The collaboration will now run until 2026. The companies have been working together to support Vertex's efforts to develop transformative medicines for serious diseases. To date, Genomics' work has focused on using improved understanding of human genetics to pinpoint causal disease pathways and processes, and to identify novel targets in known and newly identified pathways. As part of the extension, Genomics will expand the range of genomic insights it uses to support this work and expand the number of therapeutic areas under study. The partnership will now also explore using Genomics' proprietary genetic tools to improve identification of patient populations and to de-risk the selection of biomarkers for measuring early readout of drug efficacy.
|
FRES | Hot Stocks09:17 EDT Fresh2 Group announces collaboration with over 50 influencers - Fresh2 Group announced that its video e-commerce business has partnered with over 50 influencers, resulting in continued rapid sales growth. By leveraging these key partnerships, Fresh2's video e-commerce business is rapidly expanding its market presence in the e-commerce sector.
|
AMTB | Hot Stocks09:16 EDT Amerant Bank named official bank of the Tampa Bay Rays - Amerant Bank announced a multi-year strategic partnership with the Tampa Bay Rays making Amerant Bank the "Official Bank" of the team. This is the fourth major sports franchise that has partnered with Amerant - the Florida Panthers, the Miami Heat, the Miami Marlins, and now the Rays. The partnership includes the Official Bank designation, as well as a robust presence of the Amerant Bank brand in numerous locations inside the stadium and during gameday radio broadcast. Also included in the agreement are numerous hospitality opportunities, use of the Rays Trademark for promotional purposes, and select advertising placements in digital and print.
|
ET SUN | Hot Stocks09:15 EDT Energy Transfer LP, Sunoco LP form Permian Basin crude oil joint venture - Energy Transfer LP (ET) and Sunoco LP (SUN) announced the formation of a joint venture combining their respective crude oil and produced water gathering assets in the Permian Basin. Energy Transfer will serve as the operator of the joint venture and contribute its Permian crude oil and produced water gathering assets and operations. Sunoco will contribute all of its Permian crude oil gathering assets and operations to the joint venture. Energy Transfer's long-haul crude pipeline network that provides transportation of crude oil out of the Permian Basin to Nederland, Houston, and Cushing is excluded from the joint venture. As depicted in the included map, the joint venture will operate more than 5,000 miles of crude oil and water gathering pipelines with crude oil storage capacity in excess of 11M barrels. Energy Transfer will hold a 67.5% interest in the joint venture with Sunoco holding a 32.5% interest. The formation of the joint venture has an effective date of July 1, and is expected to be immediately accretive to distributable cash flow per LP unit for both Energy Transfer and Sunoco.
|
SUN ET | Hot Stocks09:12 EDT Sunoco LP, Energy Transfer LP form crude oil joint venture in Permian Basin - Energy Transfer LP (ET) and Sunoco LP (SUN) announced the formation of a joint venture combining their respective crude oil and produced water gathering assets in the Permian Basin. Energy Transfer will serve as the operator of the joint venture and contribute its Permian crude oil and produced water gathering assets and operations. Sunoco will contribute all of its Permian crude oil gathering assets and operations to the joint venture. Energy Transfer's long-haul crude pipeline network that provides transportation of crude oil out of the Permian Basin to Nederland, Houston, and Cushing is excluded from the joint venture. The joint venture will operate more than 5,000 miles of crude oil and water gathering pipelines with crude oil storage capacity in excess of 11 million barrels. Energy Transfer will hold a 67.5% interest in the joint venture with Sunoco holding a 32.5% interest. The formation of the joint venture has an effective date of July 1, and is expected to be immediately accretive to distributable cash flow per LP unit for both Energy Transfer and Sunoco.
|
PTPI | Hot Stocks09:09 EDT Petros announces results from STENDRA pivotal consumer self-selection study - Petros Pharmaceuticals announces results of the first of a series of pivotal studies aimed at facilitating FDA-approved OTC access of STENDRA for consumers. The pivotal self-selection study showed that consumers who used the Company's proprietary Web App Technology, designed to assist in the appropriate consumer self-selection for receiving the drug, had a statistically significant higher instance of correct consumer self-selection, compared to those who used a Drug Facts Label alone. The study, which evaluated 509 subjects, demonstrated a 90.6% correct consumer self-selection for those who used the Company's Web App Technology, compared to 57.3% using a DFL alone. Notably, those participants who identified as nitrate users also performed better using the Web App Technology, compared to using DFL alone, a significant difference between the two arms of the study in the high-risk population where Arm B outperformed Arm A by 67%. The pivotal self-selection study was a randomized, 2-arm, open-label, virtual, self-selection study intended to evaluate participant's self-selection with the DFL alone compared to the participant's self-selection with the DFL and the Web App Technology. Based on the FDA Proposed Rule for a Nonprescription Product with an Additional Condition of Nonprescription Use the sponsor must "demonstrate that the labeling alone... is insufficient to ensure appropriate self-selection or appropriate actual use, or both." Therefore, the results of this randomized, 2-arm pivotal all-comers self-selection study are intended to provide critical evidence required by the FDA.
|
SAVE HON | Hot Stocks09:07 EDT Spirit Airlines Honeywell appoints Richard Wallman to Board of Directors - Spirit Airlines (SAVE) has appointed Richard Wallman as its newest member of its board, effective July 16. Wallman served as CFO and SVP of Honeywell (HON), and its predecessor AlliedSignal, from March 1995 to July 2003. Prior to that, Wallman served in senior financial positions with IBM and Chrysler Corporation. He is currently a director of CECO Environmental., Charles River Laboratories International, and Roper Technologies.
|
TEAM | Hot Stocks09:07 EDT Atlassian achieves FedRAMP 'In Process' designation - Atlassian announced that it has achieved Federal Risk and Authorization Management Program, FedRAMP, "In Process" status and is now listed on the FedRAMP marketplace. This important milestone brings Atlassian one step closer to achieving FedRAMP Moderate Authority to Operate, ATO - which is currently estimated for the first quarter of calendar year 2025 - and is a significant part of Atlassian's broader investment in supporting the U.S. public sector. The company's newly announced FedRAMP Moderate offering, Atlassian Government Cloud, will initially include Jira, Confluence, and Jira Service Management. Atlassian's sponsor and partner in the ATO process is the U.S. General Services Administration GSA - a strong advocate for cloud adoption within the U.S. government..."We're excited to accelerate our investments in the public sector with FedRAMP and additional certifications in the future, so that government teams can join over 300,000 Atlassian Cloud customers and take advantage of our cloud platform for better, faster collaboration, while making sure their security requirements are met," said Rajeev Rajan, Atlassian's Chief Technology Officer
|
OP | Hot Stocks09:06 EDT OceanPal announces agreement to acquire an MR2 Tanker Vessel - OceanPal announced that it has signed, through a separate wholly-owned subsidiary, a Memorandum of Agreement to acquire an MR2 tanker vessel, the m/t Zeze Start, for an aggregate purchase price of $27.0 million from an entity controlled by a director of the Company. The transaction was unanimously approved by the Company's Board of Directors and reflects OceanPal's view that it is the right time to diversify the Company's fleet so as to take advantage of opportunities in the product tanker sector. Commenting on the transaction, Robert Perri, the Company's Chief Executive Officer, stated that, "The Board's decision to enter the product tanker space at this time marks an exciting development in the Company's corporate strategy to operate a diversified fleet amid continued optimism in the product tanker sector."
|
SLS | Hot Stocks09:06 EDT Sellas Life Sciences announces Rare Pediatric Disease Designation for SLS009 - SELLAS Life Sciences Group announced that the U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation to SLS009, a highly selective CDK9 inhibitor, for the treatment of pediatric acute myeloid leukemia. The FDA previously granted Orphan Drug and Fast Track Designations to SLS009 for the treatment of AML.
|
CMND | Hot Stocks09:06 EDT Clearmind Medicine obtains IND approval from FDA to start Phase I/IIa trial - Clearmind Medicine announced that the U.S. Food and Drug Administration, FDA, has cleared the Company's Investigational New Drug, IND, application for its proprietary MEAI-based CMND-100 oral capsule, allowing the Company to proceed with a Phase I/IIa clinical trial in the United States for treating patients with alcohol use disorder, AUD. While the Phase I/IIa clinical trial was already approved in Israel, clearance from the FDA will allow the trial to be initiated in the US. The Company has signed agreements to perform the Phase I/IIa clinical trial in leading universities in the United States, Yale School of Medicine's and the Johns Hopkins University School of Medicine. The Israeli trial will be conducted at the IMCA in the Tel Aviv suburb of Ramat Gan.
|
BAC | Hot Stocks09:05 EDT Bank of America expects low-single digit growth in loans, deposits - Says Q4 NII benefit will be smaller in 1Q25. Expects NII benefit to start rolling off in 2026.
|
MU | Hot Stocks09:05 EDT Micron now sampling multiplexed rank dual inline memory module - Micron Technology is now sampling its multiplexed rank dual inline memory module. The MRDIMMs will enable Micron customers to run increasingly demanding workloads and obtain maximum value out of their compute infrastructure. For applications requiring more than 128GB of memory per DIMM slot, Micron MRDIMMs outperform current TSV RDIMMs by enabling the highest bandwidth, largest capacity with the lowest latency and improved performance per watt to accelerate memory-intensive virtualized multi-tenant, HPC and AI data center workloads The new memory offering is the first generation in the Micron MRDIMM family and will be compatible with Intel Xeon 6 processors.
|
AA | Hot Stocks09:04 EDT Alcoa stockholder's approve proposed acquisition of Alumina - Alcoa announced the preliminary voting results of its Special Meeting of Stockholders, at which the stockholders approved the Company's issuance of shares in connection with the proposed acquisition of Alumina Limited by way of a scheme of arrangement . Approximately 99 percent of Alcoa shares present at the Special Meeting of Stockholders today voted in favor of the issuance of shares of Alcoa stock in connection with the transaction. Final voting results will be reported on a Form 8-K that the Company will file with the U.S. Securities and Exchange Commission within four business days. The proposed acquisition, when complete, will strengthen Alcoa's position as one of the world's largest bauxite and alumina producers with increased ownership of core, tier-one assets, resulting in significant and long-term value creation from greater financial and operational flexibility. "The strong support from our stockholders reflects their recognition of this strategic step to enhance Alcoa's global position as a leading pure-play, upstream aluminum company," said William F. Oplinger, President and Chief Executive Officer of Alcoa Corporation. "We are pleased to have reached this important milestone in the transaction." Alumina shareholders will consider and vote on the Scheme on July 18. The Scheme is then subject to approval by the Federal Court of Australia, at a hearing scheduled for July 22. The transaction is expected to close on or about August 1.
|
LPLA MFG | Hot Stocks09:04 EDT LPL Financial appoints Vyas as EVP, CTO of Infrastructure, Operations - LPL Financial (LPLA) announced the addition of Sushil "Sid" Vyas as Executive Vice President, EVP, and Chief Technology Officer , CTO, of Infrastructure and Operations. In his role, Vyas will oversee the stability and reliability of LPL's operating platforms. He reports to Greg Gates, Managing Director, Chief Technology and Information Officer, and is based at LPL's Fort Mill campus in South Carolina. Vyas joins LPL from Mizuho Americas (MFG) where he most recently served as chief technology officer of Mizuho America Services.
|
SNOW | Hot Stocks09:04 EDT Normalyze launches Normalyze DSPM on Snowflake Marketplace - Normalyze announced the launch of its new Snowflake Native App, Normalyze DSPM, on the Snowflake Marketplace. This launch marks a significant step in the strategic partnership with Snowflake, the AI Data Cloud company, designed to enhance organizations' data access security.
|
BX | Hot Stocks09:03 EDT Blackstone to acquire Trystar, terms undisclosed - Blackstone announced that private equity funds affiliated with Blackstone entered into a definitive agreement to acquire Trystar, a provider of electrical equipment used for backup power solutions. Trystar designs and manufactures critical electrical power solutions for data center, industrial, commercial, healthcare, and utility end markets.
|
LRCX | Hot Stocks09:02 EDT Lam Research appoints Ava Harter as Chief Legal Officer - Lam Research announced that Ava Harter has joined its executive leadership team as SVP and Chief Legal Officer. Harter most recently served as EVP and Chief Legal Officer at Whirlpoo. Previously, she served as General Counsel at Owens Corning. Prior to that, Harter held substantial legal roles at General Electric and Dow Chemical.
|
ECDA | Hot Stocks08:55 EDT ECD Automotive Design launches online merchandise storefront - ECD Auto Design announced the launch of its online merchandise storefront. This new platform provides an exclusive range of ECD-branded apparel and accessories, crafted to resonate with the loyal community of ECD enthusiasts.
|
BAC | Hot Stocks08:51 EDT Bank of America says 'strategically investing' in core businesses - Expects $4B in technology investments in 2024. Says capital position "remains strong." Says Q2 was trough in NII. Expects NII to grow in Q3 and Q4. Sees Q4 NII ~$14.5B. Expects net charge offs in 2H24 to be lower than 1H24. Comments taken from Q2 earnings conference call.
|
NEOV | Hot Stocks08:48 EDT NeoVolta announces joint venture partnership with Store Energy California - NeoVolta has announced a joint venture partnership with Store Energy California to bring state-of-the-art battery storage systems to low-income households across California. This initiative leverages state-funded incentive programs to ensure that families can access these vital technologies at no cost, enhancing their energy security and resilience. The collaboration between NeoVolta and Store Energy California aims to help low-income families utilize government programs to have battery storage installed in their homes. NeoVolta will provide cutting-edge batteries, renowned for being the longest-lasting and safest product available thanks to their superior Lithium Iron Phosphate chemistry.
|
TGL VCIG | Hot Stocks08:47 EDT Treasure Global collaborates with VCI Global, Cogia AG - Treasure Global (TGL) announces its collaboration with VCI Global (VCIG) and Cogia AG to strategically plan the rollout of VCIG Secure Cogia Messenger, an integrated secure messenger application with a cryptocurrency wallet for the ZCITY App, enhancing communication and financial services for ZCITY's 3 million users. The strategic rollout introduces the VCIG Secure Cogia Messenger, a secure messenger application that combines military-grade encryption with an integrated cryptocurrency wallet. This initiative initially targets Treasure Global's 3 million ZCITY users, aiming to achieve 1 million active users rapidly. "Our ZCITY Super App is to be a unique digital ecosystem that revolutionizes and simplifies the e-payment experience for consumers through advanced AI-powered features. We are excited to offer our ZCITY users this innovative secure messaging and payment solution. This aligns perfectly with our mission to enhance the digital lives of our users and provide them with valuable, cutting-edge services," said Carlson Thow, CEO of Treasure Global Inc.
|
MGOL | Hot Stocks08:47 EDT MGO Global sees 1H sales from Stand Flagpoles line up 12%-15% vs. last year - When the Company files its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission on or before August 14, 2024, MGO expects to report that total revenues from the sale of MGO's Stand Flagpoles' line of products for the first six months of 2024 will climb double digits on a percentage basis, rising in the range of 12%-15% as compared to the first six months of 2023. Maximiliano Ojeda, Co-Founder, Chairman and CEO of MGO, stated, "2024 is proving to be a very exciting, transformative year for MGO - and one in which our leadership team has remained dedicated to optimizing opportunities to create long-term, sustainable value for our fellow shareholders. The first half of the year has been an exceptionally busy period during which time we have successfully achieved numerous critical objectives. In June 2024, we entered into a strategic business combination agreement with Heidmar, a global, asset-light tanker pool, commercial and technical management company incorporated under the laws of the Republic of the Marshall Islands and headquartered in Greece. We believe this transaction provides a compelling and potentially transformative opportunity for our fellow MGO shareholders. The fundamental strength of Heidmar's business plan, historical financial performance including net income of $19.6 million for fiscal year ended December 31, 2023, growth outlook and respected reputation in the global maritime industry, matched with the proven experience of Heidmar's leadership team, should serve as force multipliers for attaining potentially significant value creation for MGO's shareholders in the months and years to come. MGO is very proud of our efforts to establish Stand Flagpoles as a respected niche digital brand which has continued to deliver solid performance since we first launched the patriotic-themed brand in March of 2023. It serves as a great example of MGO's approach to brand building and the strength of our digital commerce platform. In March of this year, we assigned all of MGO's rights and obligations under our global license agreement with Leo Messi Management to Centric Brands LLC, a global leading lifestyle brand collective, in a transaction that resulted in Centric paying MGO $2,000,000 in cash and assuming the obligation to pay 1.5 million Euros in aggregate royalty payments to Leo Messi Management in accordance with the terms and conditions of the license agreement. We are incredibly proud of our team's diligent efforts over the past several years, as they were behind making the Messi Brand a reality and a valued asset in MGO's portfolio of brands. We believe that our decision to enter into the transaction with Centric was the right business decision for our Company and the brand, as Centric has the deep resources necessary to take the Messi Brand to the next level. As we advance the business combination process with Heidmar towards our goal of closing in the second half of 2024, we look forward to what promises to be a very exciting future."
|
WLDS | Hot Stocks08:46 EDT Wearable Devices announces launch of Mudra LINK - Wearable Devices announced the launch of their latest in neural gesture-control technology: the Mudra LINK. This AI-powered neural wristband for any Bluetooth-enabled device promises to redefine how users interact with their digital devices, offering unparalleled functionality and compatibility.
|
TGL | Hot Stocks08:45 EDT Treasure Global collaborates with VCI Global, Cogia AG - Treasure Global announces its collaboration with VCI Global and Cogia AG to strategically plan the rollout of VCIG Secure Cogia Messenger, an integrated secure messenger application with a cryptocurrency wallet for the ZCITY App, enhancing communication and financial services for ZCITY's 3 million users. The strategic rollout introduces the VCIG Secure Cogia Messenger, a secure messenger application that combines military-grade encryption with an integrated cryptocurrency wallet. This initiative initially targets Treasure Global's 3 million ZCITY users, aiming to achieve 1 million active users rapidly. "Our ZCITY Super App is to be a unique digital ecosystem that revolutionizes and simplifies the e-payment experience for consumers through advanced AI-powered features. We are excited to offer our ZCITY users this innovative secure messaging and payment solution. This aligns perfectly with our mission to enhance the digital lives of our users and provide them with valuable, cutting-edge services," said Carlson Thow, CEO of Treasure Global Inc.
|
THAR | Hot Stocks08:44 EDT Tharimmune launches new website amid continuing discussions wtih FDA - Tharimmune announces the launch of its new website at www.tharimmune.com. This redesigned online platform provides patients, healthcare professionals and stakeholders with comprehensive information about Tharimmune's cutting-edge research, ongoing clinical trials and corporate developments. The new website features a user-friendly interface, detailed sections on Tharimmune's pipeline of investigational therapies, including its lead candidate, TH104, and resources for patients and caregivers. Visitors will also find the latest news and updates, company-produced content, scientific publications, upcoming events and opportunities for collaboration. In tandem with the launch of the new website and following a productive Type C meeting with the U.S. Food and Drug Administration, Tharimmune is continuing discussions with the FDA, regarding the study design and initiation of a Phase 2 clinical trial for TH104 in moderate-to-severe chronic pruritis in primary biliary cholangitis.
|
SWIM | Hot Stocks08:43 EDT Latham Group appoints Vaughan as CHRO - Latham Group announced that it has named Nikki Vaughan as Chief Human Resources Officer, CHRO. Vaughan will lead Latham's human resources organization, responsible for aligning Latham's talent strategy with the company's strategic business objectives. Most recently, Vaughan served as Chief People Officer at Sedron Technologies.
|
MASI | Hot Stocks08:42 EDT Masimo holder Politan comments on company's 'latest entrenchment maneuvers' - Politan Capital Management an 8.9% shareholder of Masimo responded to the Company's Board of Directors moving Masimo's Annual Meeting of Stockholder previously scheduled for July 25 to September 19. Politan also commented on the Board bringing a lawsuit in federal court against Politan and its founder and CIO Quentin Koffey. Mr. Koffey is also a member of the Masimo Board. On Monday, ISS wrote that Masimo, "has a corporate governance track record that is firmly among the most troubling of any modern public company," and that CEO and Chairman Joe Kiani, "has demonstrated that he has no regard for public shareholders. He has been at the center of so many corporate governance scandals and abuses that no credible argument exists to the contrary." Today's actions are more of the same. This is not about Politan's proxy materials. There are no misstatements. Politan has never had any contact with "plaintiff's counsel" involving litigation against Masimo and does not even know what Mr. Kiani is referring to. The reality is that moving the Annual Meeting - which was scheduled to be held in nine days - back two months is nothing more than a desperate attempt to prevent the voices of Masimo's shareholders from being heard. Despite Masimo's bylaws and Delaware law requiring the Company hold an Annual Meeting within 13 months of the last one, Mr. Kiani is delaying the Annual Meeting to a date 15 months past the last meeting, and he has calculated that the time it takes for Politan to go to court and compel a meeting could allow him to get away with such a substantial delay. As Politan made clear in a letter sent to the Board on July 15, even if the Board truly wanted to address the empty voting issue, there was no need for the meeting to be rescheduled for any later than August 5."
|
BBKCF | Hot Stocks08:42 EDT Bigg Digital Assets doubles sales division amid digital asset sector expansion - As part of its strategic growth plan, BIG has doubled the size of its sales organization to help meet the interest and demand for on-chain tools and technology as the digital asset market grows. BIG seeks to penetrate new markets and strengthen its presence in existing ones. With a larger sales force, BIG can provide more personalized and responsive customer service, ensuring that clients receive the attention and support they need to maximize the value of BIG products. Our expansion aims to capitalize on the ever increasing market opportunities, drive broader adoption of its innovative product suite, and deliver an exceptional customer experience. BIG has seen rising institutional interest and investment in the digital assets space, increased regulatory clarity, and the recent launch of new ETFs in the United States. Additionally, the anticipation of more ETFs soon to be launched globally is creating a surge in demand for services like ours, as institutional investment firms seek robust solutions for compliance, intelligence, and analytics in the digital assets sector.
|
CDXC | Hot Stocks08:42 EDT ChromaDex to debut pharmaceutical-grade Niagen at clinics in August - ChromaDex announced Wells Pharma of Houston will begin shipping limited quantities of pharmaceutical-grade Niagen, branded Niagen+, to select IV clinics including Cenegenics, Clean Market/NutriDrip, Drip Hydration, EXTEN IV, Kensho Wellbeing, The NAD MD, Next Health, The Remedy Room, Restore Hyper Wellness, and REVIV in August, with additional clinics set to receive shipments soon after. U.S. FDA-registered 503B outsourcing facility, Wells Pharma of Houston, will compound and distribute pharmaceutical-grade intravenous, or IV, and injectable Niagen, which will be available in IV, shots, and intravenous-push forms exclusively at clinics, with a prescription.
|
LGCL | Hot Stocks08:41 EDT Lucas GC receives invention patent in AI in China - Lucas GC has received an invention patent "Artificial Intelligence Enabled Prescriptive Persuasion Processes Based on Speech Emotion Recognition and Sentiment Analysis" in China. This is the second patent that Lucas has obtained in the year of 2024, making the total number of patents that Lucas holds at eighteen. This patent relates to methods and systems provided for the AI-based computer-aided persuasion system. The CAPS obtains content output by analyzing the user audio stream and the target audio stream using neural network models, and generates persuasion references that increase the acceptance likelihood of recommendations.
|
OCTO | Hot Stocks08:41 EDT Eightco Holdings provides shareholder update - Eightco Holdings provides an update to its shareholders regarding recent activities and future initiatives for growth. The Company has made significant progress in the first half of 2024 improving its financial condition, most notably through the elimination of $5.4 million in convertible notes and increasing shareholder equity by over $23 million which allows a renewed focus on the growth of its subsidiary, Forever 8 Fund. During 2024, the Company eliminated significant costs and roles related to the management of various legacy businesses. The Company's primary focus now is the growth of Forever 8, which operates in two main areas: providing inventory solutions for small to mid-sized e-commerce sellers and supplying refurbished Apple products for sellers in the United Kingdom and European Union. Overall, Significant Improvement in Financial Condition Allows Renewed Focus on Revenue Growth.
|
CNTM | Hot Stocks08:40 EDT ConnectM launches intelligent heat pump system - ConnectM Technology Solutions announced the launch of its new intelligent heat pump system designed for residential and light commercial use. This system integrates with ConnectM's Energy Intelligence Network and features an IoT-enabled AI engine powered by a large language model trained on proprietary and public data. The AI optimizes performance and efficiency, reducing energy costs and carbon footprint. The Energy Intelligence Network is ConnectM's comprehensive technology platform that monitors and manages electrified assets throughout their lifecycle and collects anonymized performance data to refine artificial intelligence models while continually improving network performance. This infrastructure enables OEMs, third-party service providers and consumers to work towards decarbonization and net zero goals.
|
NNE | Hot Stocks08:39 EDT Nano Nuclear Energy invited to U.S. Industry Program at IAEA General Conference - NANO Nuclear Energy was recently invited as a trade mission member for the upcoming annual U.S. Industry Program at the IAEA General Conference, to be held on September 15-18, 2024, in Vienna, Austria. Organized by the U.S. Department of Commerce's International Trade Administration, with participation from the U.S. Departments of Energy and State, the U.S. Industry Program is part of the DOC's Civil Nuclear Trade Initiative, a U.S. government effort to help U.S. civil nuclear companies identify and capitalize on commercial civil nuclear opportunities around the world. The U.S. Industry Program provides its participants with valuable market insights, industry connections, and opportunities to refine business strategies and advance specific projects.
|
NTWK | Hot Stocks08:37 EDT NetSol Technologies signs $16M agreement with major automaker - NETSOL Technologies has signed an agreement with a major automaker to transform its US dealership operations. The $16M, five-year contract is for the customization, implementation, deployment, and ongoing SaaS subscription of Otoz, NETSOL's omnichannel digital retail platform. "We are thrilled to collaborate with one of the world's leading automakers to enhance the car sales and purchase process for their dealerships and customers," said Naeem Ghauri, President NETSOL Technologies and Founder of Otoz. "Building off the recent US-market traction with MINI Anywhere and AutoNation Mobility, this new partnership is a monumental milestone for the Otoz platform, underscoring the transformative potential of NETSOL's competence in redefining digital retail experiences and aligning with the evolving demands of the automotive sector."
|
WKHS | Hot Stocks08:37 EDT Workhorse awarded Sourcewell contract for zero-emission commercial vehicles - Workhorse Group announced that it has been awarded a Sourcewell contract for procurement in the category of Class 4-8 chassis and cabs with related equipment, accessories, and services. This significant achievement allows Workhorse to expand its reach to government, educational, and nonprofit sectors within all 50 states and Canada.
|
LUNR | Hot Stocks08:36 EDT Intuitive Machines qualifes VR900 engine for IM-2 lunar mission - Intuitive Machines has qualified the VR900 engine for its IM-2 lunar mission, which also advances the development of the Company's VR3500 engine for larger cargo class landers. Designed, 3D-printed, and tested in-house, the IM-2 VR900 engine completed a full-duration hot-fire test that confirmed increased engine performance utilizing efficient design modifications. Intuitive Machines engineers are applying the design modifications and quality processes to its larger engine system while completing the IM-2 mission lander's final assembly. The scalable VR900 engine uses an environmentally friendly mix of liquid oxygen and methane to support science and discovery payload deliveries to the Moon. Intuitive Machines first validated the proprietary propulsion system through the first-ever deep space ignition, followed by multiple restarts, repeatedly providing successful spacecraft maneuvers on the IM-1 mission in February 2024.
|
CENN | Hot Stocks08:36 EDT Cenntro gets CARB executive order certifying Logistar 300 model - Cenntro announces Cenntro received a California Air Resources Board CARB, Executive Order and a "Certificate of Conformity" from the United States Environmental Protection Agency EPA for the Logistar 300, LS300 model. On June 21 Cenntro received the CARB Executive Order certifying the all-electric, light-duty, class 3 LS300 model meets the standard to be considered zero-emissions vehicles in California. Similarly, the Certificate of Conformity confirms that the LS300 meets the EPA's emissions requirements under the Clean Air Act. The LS300 model is the latest addition to Cenntro's product portfolio for the U.S. market. The CARB and the EPA certifications position Cenntro's California-based customers to apply for end purchaser incentives such as participation in the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project
|
HOTH | Hot Stocks08:35 EDT Hoth Therapeutics expands Phase 2a of HT-001 trial for skin cancer - Hoth Therapeutics has received written approval from the GW University Hospital, UC Irvine and Northwell Health to proceed with its First-in-Human Phase 2a clinical trial of HT-001 for the treatment of skin toxicities associated with Epidermal Growth Factor Receptor Inhibitors. This Phase 2a dose- ranging study to investigate the efficacy, safety, and tolerability of topical HT-001 for the treatment of skin toxicities associated with EGFRi.
|
BDRX | Hot Stocks08:35 EDT Biodexa Pharmaceuticals announces Phase 2a study of tolimidone in T1D - Biodexa Pharmaceuticals announces progress on initiation of a Phase 2a study of tolimidone in Type 1 diabetes, T1D. Health Canada has approved a Phase 2a dose confirmation study of tolimidone in T1D. The study will be an Investigator Initiated Trial, IIT, to be conducted by the University of Alberta. The study will measure C-peptide levels and HbA1c after three months compared with baseline and the number of hyperglycemic events initially in 12 patients across three dose groups. The study may be expanded in due course. It is expected the first patient will be enrolled in the current quarter. Commenting, Stephen Stamp, CEO and CFO of Biodexa said: "We are excited to initiate our clinical program in Type 1 diabetes with the University of Alberta and build on the extensive tolimidone data package put together by Pfizer, Melior and Bukwang ".
|
SHFS | Hot Stocks08:35 EDT SHF Holdings submits comments to DOJ on cannabis rescheduling - SHF Holdings it has submitted comments to the Justice Department, following its recent proposed rule to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act, consistent with the view of the Department of Health and Human Services that cannabis has a currently accepted medical use as well as HHS's views about marijuana's abuse potential and level of physical or psychological dependence. For the past 54 years, cannabis has been categorized as a Schedule I controlled substance under the Controlled Substances Act. Schedule I drugs, substances or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. The publication of this proposed rule initiates a public comment period that will remain open until July 22, 2024. Comments can be submitted electronically via the Federal eRulemaking Portal using the reference: 'Docket No. DEA-1362.'
|
DRIO | Hot Stocks08:34 EDT DarioHealth expands GLP-1 solution client base with new employer contract - DarioHealth announced a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in Q3. The employer, a provider of environmental services, selected Dario's cardiometabolic suite to address multiple health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including integrated support for those employees taking a GLP-1 medication.
|
REBN | Hot Stocks08:33 EDT Reborn Coffee signs MOU to acquire Bbang Ssaem Bakery - Reborn Coffee announces the signing of a Memorandum of Understanding, MOU, to acquire Bbang Ssaem Bakery, one of Korea's most iconic bakery brands. This strategic move will upgrade Reborn Coffee's footprint into the coffee and bakery sector, enhancing its offerings and solidifying its position as a premier coffee & bakery franchise in the United States & South Korea.
|
CAAP | Hot Stocks08:33 EDT Corporacion America Airport reports June traffic down 8.9% - Corporacion America Airport reported an 8.9% year-on-year decrease in passenger traffic in June. Excluding Natal for comparison purposes, total traffic in June decreased by 6.7% YoY.
|
APO | Hot Stocks08:32 EDT Apollo Global to acquire The Travel Corporation, terms not disclosed - Apollo and The Travel Corporation announced they have entered into definitive agreement for Apollo-managed funds to acquire TTC, which has been privately owned and operated for more than a century. The transaction is comprised of 18 leading brands, including Trafalgar, a leading escorted tour operator; Uniworld Boutique River Cruises, a luxury all-inclusive river cruise line; Contiki, youth travel specialist tour company; premium guided vacation company, Insight Vacations; as well as other global travel brands and supporting business entities. The transaction is subject to satisfaction of certain closing conditions, including regulatory approvals, and is expected to close in the fourth quarter of 2024. Certain brands are not included in the sale, notably The Red Carnation Hotel Collection. Financial terms of the transaction are not disclosed.
|
IMAX | Hot Stocks08:32 EDT Imax partners with Saudi Arabia's muvi Cinemas for four new laser locations - Imax and muvi Cinemas, the largest exhibitor in Saudi Arabia, announced their first-ever collaboration with an agreement for four new Imax with Laser systems across some of the biggest commercial centers in the country. muvi Cinemas will bring two Imax systems to Saudi Arabia's capital and most populous city, Riyadh; one system to Jeddah's Mall of Arabia; and the first Imax system to Dhahran. Three of the new locations are scheduled to open by the end of 2024, with an additional location to follow in 2025. IMAX currently has 10 open locations in Saudi Arabia, with another 22 slated to open inclusive of its partnership with muvi. IMAX estimates it can open at least 50 locations in the country.
|
ICU | Hot Stocks08:32 EDT SeaStar Medical announces receipt of Category B Coverage Letter from CMS - SeaStar Medical announces receipt of a Category B Coverage Letter from the U.S. Centers for Medicare & Medicaid Services, CMS, for the NEUTRALIZE-AKI pivotal trial evaluating the Company's Selective Cytopheretic Device, SCD, in adults with acute kidney injury, AKI. CMS will pay for certain expenses incurred by medical centers treating patients covered by Medicare or Medicaid who are enrolled in the trial, which will cover a portion of SeaStar Medical's trial-related costs. "We anticipate that CMS reimbursement will provide substantial overall cost savings for this trial while accelerating the activation of new sites, including several that have been waiting for this determination. With more trial sites activated we expect a meaningful acceleration in patient enrollment," said Eric Schlorff, SeaStar Medical CEO.
|
SNTI | Hot Stocks08:31 EDT Senti Bio announces 1-for-10 reverse stock split - Senti Biosciences announced that its Board of Directors has determined to effect a one-for-ten, 1-for-10, reverse stock split of Senti Bio's common stock, par value $0.0001 per share. The reverse stock split will take effect on July 17, 2024, and Senti Bio's common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market as of the opening of trading on July 18, 2024. The CUSIP number of 81726A209 will be assigned to Senti Bio's common stock when the reverse stock split becomes effective.
|
JCSE | Hot Stocks08:27 EDT JE Cleantech announces grant of temporary exception to remain listed on Nasdaq - JE Cleantech Holdings received a letter from the Listing Qualifications Department of The Nasdaq Stock Market. The Exception Letter gave the Company a temporary exception to regain compliance with The Nasdaq Stock Market's Listing Rule 5550(a)(2). The Exception Letter stated: Accordingly, the Company is granted an exception until December 6, 2024, to effect the reverse stock split and thereafter regain compliance with the Bid Price Rule, subject to the milestones outlined below. In the event the Company fails to regain compliance with the Bid Price Rule by that date, its securities will be delisted. On or before November 14, 2024, the Company shall obtain shareholders approval for a reverse stock split at a ratio that satisfies the minimum requirement in the Bid Price Rule; On or before November 21, 2024, the Company shall effect a reverse stock split and, thereafter, maintain a $1 closing bid price for a minimum of ten consecutive business days; On or before December 6, 2024, the Company shall have demonstrated compliance with the Bid Price Rule, by evidencing a closing bid price of $1 or more per share for a minimum of ten consecutive trading sessions. The Panel reserves the right to reconsider the terms of this exception based on any event, condition or circumstance that exists or develops that would, in the opinion of the Panel, make continued listing of the Company's securities on the Exchange inadvisable or unwarranted. In that regard, the Panel advises the Company that it is a requirement during the exception period that the Company provide prompt notification of any significant events that occur during this time that may affect the Company's compliance with Nasdaq requirements. This includes, but is not limited to, prompt advance notice of any event that may call into question the Company's ability to meet the terms of the exception granted.
|
MGRX | Hot Stocks08:27 EDT Mangoceuticals secures FDA approval for HIPAA-compliant operating system - Mangoceuticals announces obtaining DEA authorization for the company's groundbreaking HIPAA-compliant operating system through Surescripts. This significant milestone positions MangoRx at the forefront of the direct-to-consumer, DTC, telemedicine market. Securing DEA clearance to prescribe controlled medications via Surescripts, the nation's leading health information network, sets MangoRx apart from its competitors, validating its cutting-edge technology and regulatory compliance. This approval aims to give MangoRx's provider network more flexibility in prescribing custom medication and treatments to include a comprehensive range of controlled substances such as hormone replacement therapies - which they anticipate will drive significant growth in this category. The DEA approval provides a robust foundation for the company's future expansion and success, ensuring adherence to stringent regulatory standards while fostering innovation.
|
VTAK | Hot Stocks08:26 EDT Catheter Precision completes patient follow-up for VIVO European Registry - Catheter Precision announced that the patient follow-up phase for the VIVO European Registry has concluded. The EU registry began in October 2021 and patient enrollment concluded in June 2023. As previously disclosed, the EU registry enrolled 125 patients with an aim to gather real world data about the use and benefits of VIVO, outside of a rigorous clinical study. The data serves multiple purposes including fulfilling European regulatory requirements for on-going data collection, publication of multi-center data, and future development of studies and improvements to the VIVO technology, including a demonstration of the accuracy and benefits of VIVO for pre-procedure planning of ventricular ablation. The data is expected to become available in Q4 2024. In addition to the conclusion of the EU Registry, Catheter Precision continues the ongoing studies it has previously disclosed as part of its commitment to gathering and publishing clinical data for the company's two product lines, VIVO and LockeT. The Company also announced additional initial evaluations of VIVO. During July, three new European hospitals are beginning product evaluations including Manchester University NHS, Wythenshawe Hospital, Institute for Clinical and Experimental Medicine, and Cardinal Massaia Hospital (Italy). In addition, two new US hospitals in California and Washington have been in-serviced and are scheduled to begin VIVO procedures this month as part of such initial evaluations.
|
UMAC | Hot Stocks08:24 EDT Unusual Machines launches Rotor Riot Brave F7 Flight Controller - Unusual Machines announced the launch of the Rotor Riot Brave F7 Flight Controller. This product is manufactured in the USA and is fully compliant with the National Defense Authorization Act. Starting today, the Rotor Riot Brave F7 Flight Controller is available for pre-sale at an introductory price of $49.50 on the Rotor Riot e-commerce store. The special introductory price expires on August 15, 2024. The first orders are expected to start shipping early in August. The Rotor Riot Brave F7 Flight Controller is also available for wholesale purchase to other retailers, enterprise, and government customers.
|
IREN MS | Hot Stocks08:20 EDT Iris Energy appoints Morgan Stanley as Financial Advisor - IREN (IREN) provided a business update. The Company announces it has appointed Morgan Stanley & Co. (MS) as financial advisor in connection with evaluating monetization opportunities in the AI data center market.
|
ONVO | Hot Stocks08:19 EDT Organovo presented on near term catalysts at Jones Trading Conference - Organovo Holdings announced that Executive Chairman Keith Murphy presented on the company's near and long-term outlook, operational plans, at the Jones Trading Healthcare Conference in Encinitas, CA. "The promise of FXR314 is strong and I encourage investors to review our newest presentation," said Keith Murphy, Executive Chairman. "As mergers and acquisitions continue to be strong in inflammatory bowel disease, highlighted by the Lilly acquisition of Morphic for $3.2B after strong Phase 2a results, we are encouraged by our progress and our near-term opportunity to show the value of FXR314 in IBD in our own Phase 2a trial. Completing the trial swiftly is important for our investors and for patients, as we expect to demonstrate activity of FXR314 that matches the strong results we've seen in a highly predictive preclinical animal model, as well as the strong data demonstrating the impact of FXR314 to relieve disease aspects in our 3d human models of ulcerative colitis and Crohn's disease."
|
SEZL | Hot Stocks08:17 EDT Sezzle unveils Spanish-language capabilitiy on BNPL app - Sezzle unveils Spanish-language capability on its BNPL app and checkout, signaling a significant move towards inclusivity for Spanish-speaking users. With over 40 million Spanish-speaking Americans, this endeavor aims to offer accessible financial solutions to this demographic, aligning with Sezzle's mission to financially empower the next generation
|
TDOC | Hot Stocks08:16 EDT Teladoc introduces metal healthcare through partnership with Brightline - Teladoc Health announced the availability of comprehensive mental healthcare for children, adolescents, and their families. The innovative offering, in partnership with Brightline, is offered through Teladoc Health's virtual "front door," connecting members to the healthcare they need, and increasing access to mental healthcare providers specifically trained in pediatric, adolescent and family mental health. "As part of our unwavering commitment to deliver trusted care across the ages and stages of life, we are proud to expand mental health support for this age group and tap into Brightline's comprehensive and responsive model of care, network of specialists, and robust digital platform to provide this extremely vital service to our clients and members," said Teladoc Health Chief Medical Officer Dr. Vidya Raman-Tangella. "We believe that access to mental health services earlier in life is a vital first step for younger generations to take charge of their healthcare journeys."
|
VRT | Hot Stocks08:16 EDT Vertiv Holdings to add ZincFive BC series UPS battery cabinets - Vertiv and ZincFive, NiZn battery-based solutions for immediate power applications firm, announced that Vertiv will add the ZincFive BC Series uninterruptible power supply UPS Battery Cabinets to its portfolio of battery systems available for data center backup power. ... The ZincFive BC Series UPS Battery Cabinets are now available from Vertiv in North America and Europe, Middle East and Africa...."Vertiv and ZincFive want to enable reliable and efficiently operated data centers around the world, providing greater access to data, with less waste and greater energy efficiency," said Vertiv senior director of Energy Storage, Milind Paranjape. "Vertiv has already deployed the ZincFive product at several sites for major data center companies." Paranjape also said the technology is an excellent solution for customers faced with challenges with local Authorities Having Jurisdiction (AHJs) regarding National Fire Protection Association or NFPA standards and the International Fire Code, IFC .
|
BTM | Hot Stocks08:15 EDT Bitcoin Depot announces sale of 200 additional BTM kiosks - Bitcoin Depot announced sale of 200 additional BTM kiosks to Sopris Capital, a 20-year-old multi-strategy investment firm as part of the Company's profit-sharing program. Bitcoin Depot launched the program in 2023 to provide additional deployment opportunities to qualified partners as part of its North American expansion strategy. Today's news follows the March announcement, where Sopris joined Bitcoin Depot's profit-sharing program with the purchase of 50 kiosks. "Our decision to purchase additional kiosks underscores the attractiveness of this investment opportunity, and the confidence we have in Bitcoin Depot's strategy and growth potential," said Andrew Paul, Founder and CEO of Sopris Capital. "As an owner of 250 kiosks and one of the Company's independent shareholders, we believe Bitcoin Depot presents multiple ways to drive high returns on our capital."
|
CLDX | Hot Stocks08:15 EDT Celldex initiates global Phase 3 program for barzolvolimab in CSU - Celldex Therapeutics announced the initiation of its global Phase 3 program, consisting of two Phase 3 trials designed to establish the efficacy and safety of barzolvolimab in adult patients with CSU who remain symptomatic despite H1 antihistamine treatment. The studies will also include patients who remain symptomatic after treatment with biologics. For patients with CSU, the activation of mast cells in the skin results in episodes of itchy hives, swelling and inflammation of the skin that can severely impact their daily lives for years or even decades. Treatment options are limited, particularly for patients not adequately controlled by omalizumab. Barzolvolimab, a novel monoclonal antibody, works upstream of other treatment approaches for CSU, targeting the root driver of the disease-mast cells-by blocking the receptor tyrosine kinase KIT, which is required for mast cell function and survival. EMBARQ-CSU1 and EMBARQ-CSU2 are designed to establish the efficacy and safety of barzolvolimab in adult patients with CSU who remain symptomatic despite H1 antihistamine treatment. Both Phase 3 trials are randomized, double-blind, placebo-controlled, parallel group, global studies where approximately 915 patients will be randomized evenly to barzolvolimab 150 mg every 4 weeks, barzolvolimab 300 mg every 8 weeks or placebo for 52 weeks. At 24 weeks, patients on placebo will be re-randomized to active treatment across both dosing groups. The primary endpoint of the study will evaluate the clinical effect of barzolvolimab in reducing urticaria activity at Week 12. The study is designed to detect a clinically meaningful difference between each of the active arms vs placebo in the overall population as well as in the subpopulation of omalizumab refractory participants.
|
LOBO | Hot Stocks08:13 EDT LOBO EV establishes office in Suriname to boost Latin American presence - LOBO EV Technologies announced that it will open a new office in Suriname to better serve the rapidly growing Latin American market. This strategic expansion is in response to increasing demand for sustainable electric mobility solutions in the region. The new office to be established through a Memorandum of Understanding, MOU, with Zhongda International Engineering Company N.V., a Suriname company, encompasses approximately 2,152 square feet of office space and includes a 5,381 square feet warehouse. This space will support LOBO's operations and serve as a temporary product transfer and distribution center. The office is located in Wanica, Suriname, on a site that provides ample space for future development and potential assembly plant operations.
|
HUMA | Hot Stocks08:12 EDT Humacyte appoints John Bamforth, Keith Anthony Jones to board of directors - Humacyte announced the addition of John Bamforth and Dr. Keith Anthony Jones to the Company's Board of Directors. John P. Bamforth, PhD has served as Executive Director of Eshelman Innovation, a translational innovation institute at the University of North Carolina-Chapel Hill, since 2019. Keith Anthony Jones, M.D., has served as the Chief Physician Executive of the University of Alabama at Birmingham Health System since 2017.
|
AXTA | Hot Stocks08:12 EDT Axalta Coating announces partnership with CESVIMAP, the Move2Green program - Axalta announced a partnership with CESVIMAP R&D Centre. Through this partnership, Axalta's refinish customers will have access to CESVIMAP's Move2Green sustainability program which offers an online, self-assessment questionnaire to evaluate the current environmental impact of bodyshops. Once an auditor analyzes the data, Axalta customers will receive a detailed roadmap with actionable steps to improve their sustainability initiatives as well as the Move2Green certification to promote their commitment to reducing their environmental footprint.
|
ACN | Hot Stocks08:12 EDT Accenture to acquire retail technology services firm Logic, no terms - Accenture has entered into an agreement to acquire Logic, a retail technology services firm that works with retailers to drive customer loyalty, boost revenue and increase agility through the use of technology. With strong capabilities in merchandising, stores, digital, analytics and cloud, the acquisition of Logic will further enhance Accenture's ability to drive technology transformations for retail clients globally...Logic will expand Accenture's retail capabilities with the addition of essential skills in core technologies and platforms, as well as artificial intelligence and generative AI, to drive innovation for clients. This strategic move underscores Accenture's commitment to helping retailers transform their organizations with technology so that they can better navigate the evolving retail landscape with confidence....Completion of the acquisition is subject to customary closing conditions, including receipt of regulatory approvals. Terms of the transaction were not disclosed
|
VYNE | Hot Stocks08:11 EDT VYNE Therapeutics announces granting of composition of matter patent for VYN202 - VYNE Therapeutics announced GB Patent No. 2621505 entitled "Pyrrolopyridone derivatives useful in the treatment of inflammatory disorders, immune disorders and cancer" has been granted by the United Kingdom's Intellectual Property Office. This granted patent covers the compound in VYNE's VYN202 program and has a 20-year term that will expire in June 2042. "The granting of this composition of matter patent is key to the development of VYN202, which we believe is the most potent and BD2-selective BET inhibitor in development," said David Domzalski, President and Chief Executive Officer of VYNE. "Obtaining intellectual property protection is an important value driver for VYNE and we will continue to seek protection in additional jurisdictions as we progress our BET inhibitor pipeline."
|
PLBY | Hot Stocks08:11 EDT PLBY Group enters long-term license agreement for condoms - PLBY Group has entered into a new, multi-year global product license agreement with Thai Nippon Rubber Industry Public Limited Company granting TNR rights to design, produce, promote and distribute condoms and lubricating gel products using PLAYBOY trademarks through multiple online and retail channels. PLBY Group will receive royalty payments, including minimum guarantees, on products sold pursuant to the agreement. The new license agreement was entered into by PLBY Group and TNR concurrently with a settlement agreement pursuant to which the companies resolved a lawsuit between them in the U.S. District Court for the Central District of California. The lawsuit related to a prior license agreement pursuant to which TNR had manufactured and sold condoms under the Playboy brand. PLBY Group expects the dismissal of the lawsuit with prejudice to be entered by the court as soon as reasonably practicable. No party to the lawsuit admitted any liability or wrongdoing in connection with the settlement agreement.
|
LXRX | Hot Stocks08:10 EDT Lexicon receives PDUFA goal date for resubmission of NDA for Zynquist - Lexicon Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has acknowledged the resubmission of its New Drug Application, NDA, for Zynquist as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes and chronic kidney disease, CKD. The FDA indicated that it considers the resubmission to be a complete response to the FDA's 2019 action letter regarding the sotagliflozin NDA for type 1 diabetes, providing a Prescription Drug User Fee Act, PDUFA, goal date of December 20, 2024. "Lexicon has continued confidence in the favorable benefit/risk profile of sotagliflozin for adults with type 1 diabetes and CKD. With a PDUFA date now in hand, we can begin the next phase of launch preparation for Zynquista," said Dr. Mike Exton, chief executive officer and director. "If approved, this will mark Lexicon's second NDA approval and commercial launch in two years of products that originated from our novel discovery platform and advanced to regulatory approval and commercialization. With an exciting and diverse portfolio of assets, Lexicon is well-positioned for strong future value creation for all stakeholders."
|
OTRK | Hot Stocks08:10 EDT Ontrak adopts CHI framework to enhance care delivery - Ontrak announces the adoption of the Comprehensive Healthcare Integration or CHI, framework into its care delivery model. This advances Ontrak Health's commitment to delivering high quality, integrated, whole person care. The CHI model represents the most comprehensive clinical framework for integrating physical health, behavioral health, and social determinants of health within care delivery. Developed by the National Council for Mental Wellbeing in 2022, the CHI framework provides a robust foundation for implementing and measuring the progress of integrated healthcare services. The CHI white paper explains, "The evidence strongly suggests that people of all ages living with co-occurring PH, BH and SDOH needs have higher health costs yet experience poorer health outcomes. Emerging evidence suggests that more coordinated or integrated oral, mental health and substance use treatment services can increase access to needed care, improve patient outcomes and potentially reduce healthcare costs. The evidence further suggests that populations with co-occurring PH, BH and SDOH needs are likely to benefit from evidence-based integrated interventions in whatever setting they are best engaged, with more complex and high-cost populations generally requiring higher levels of service intensity." "With the adoption of the CHI framework we are unlocking the full potential of integrated care through our clinical programs," said Dr. Judith Feld, Chief Medical Officer of Ontrak Health. "We are proud to champion the evolution of care delivery, harnessing the power of integrated care to improve patient lives."
|
CLDI | Hot Stocks08:09 EDT Calidi appoints Mark Gilbert to Medical Advisory Board - Calidi Biotherapeutics announced the appointment of Mark Gilbert, MD, scientist emeritus at the National Institutes of Health, to its Medical Advisory Board. This addition increases the board's membership to eight. Dr. Gilbert most recently served as the Chief of the Neuro-Oncology Branch at NIH from 2014 to 2024.
|
MSFT | Hot Stocks08:08 EDT U.K.'s CMA starts probe into Microsoft hiring former Inflection AI staff - The U.K.'s Competition and Markets Authority announced that it is investigating Microsoft's hiring of certain former employees of Inflection AI and its entry into associated arrangements with Inflection. "The CMA is considering whether it is or may be the case that Microsoft Corporation's hiring of certain former employees of Inflection and its entry into associated arrangements with Inflection has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services." The regulator has until September 11 to decide whether or not it would refer the deal for a more in-depth investigation. Reference Link
|
LSTA | Hot Stocks08:08 EDT Lisata Therapeutics completes enrollment in Phase 2a BOLSTER trial - Lisata Therapeutics announced the early completion of enrollment in its Phase 2a BOLSTER trial evaluating certepetide, Lisata's investigational product, as a treatment for first-line cholangiocarcinoma. This key milestone comes nearly six months sooner than originally expected. The BOLSTER trial is a Phase 2a double-blind, placebo-controlled, multi-center, randomized study evaluating certepetide in combination with standard-of-care versus standard-of-care alone in patients with first-line CCA in the United States. The rapid enrollment of this cohort underscores the urgent need for new treatment options for patients with CCA, a difficult-to-treat solid tumor with a poor prognosis. Based on this rapid enrollment rate and the pressing need to improve treatment outcomes in second-line CCA, Lisata has added an arm to the BOLSTER trial evaluating second-line CCA. The Company expects to enroll the first patient in the second-line CCA arm by the fourth quarter of 2024.
|
BTOC MAMO | Hot Stocks08:07 EDT Armlogi Holding provided update on partnership with Massimo - Armlogi Holding (BTOC) provided an update on its strategic partnership with Massimo Group (MAMO), highlighting progress in their efforts to enhance vehicle storage and transportation services across the United States. The collaboration aims to streamline operations and improve service delivery to meet the rising demand in the power sports vehicle market. The Partnership has seen steady progress, with Massimo integrating its quality control standards into the operational framework of Armlogi's distribution processes. This integration is meant to elevate the quality and reliability of logistics services, ensuring that all products delivered through Armlogi's network meet Massimo's standards. As a result of the collaborative efforts with Massimo, Armlogi now independently manages their deliveries across various regions.
|
RKLB | Hot Stocks08:07 EDT Rocket Lab in preliminary deal under U.S. CHIPS/Science Act in Albuquerque - Rocket Lab welcomed government and community leaders at its space-grade solar cells manufacturing facility in Albuquerque, New Mexico, on Monday, July 15 to celebrate Rocket Lab's signed preliminary agreement under the U.S. CHIPS and Science... Rocket Lab executive leadership, Congressional leaders and state and local officials took part in the event to celebrate the preliminary agreement which would assist in the modernization and expansion project to increase the Company's compound semiconductor production for spacecraft and satellites, helping to domestically meet the growing national security and consumer demand for these solar cells.
|
SNN | Hot Stocks08:07 EDT Smith & Nephew announces 510(k) clearance for CATALYSTEM Primary Hip System - Smith+Nephew has received 510(k) clearance for its new CATALYSTEM Primary Hip System from the United States Food and Drug Administration. The system is designed to address the evolving demands of primary hip surgery including the increased adoption of anterior approach procedures and the expanding role of Ambulatory Surgery Centers.
|
KPLT | Hot Stocks08:06 EDT PayTomorrow integrates Katapult into its waterfall application process - Katapult Holdings announced a strategic partnership with PayTomorrow, a premier waterfall financing platform. Through this partnership, PayTomorrow has integrated Katapult's unique, customer-centric lease-to-own option into PayTomorrow's suite of financial products, providing consumers with greater flexibility and choice. This integration embeds Katapult's innovative LTO within PayTomorrow's platform. PayTomorrow's platform provides merchants with a range of payment options that serve prime, near prime and nonprime consumers.
|
ESPR | Hot Stocks08:05 EDT Esperion announces 'Lipid Lurkers' digital first marketing campaign - Esperion is on a mission to educate patients on the cardiovascular risks of uncontrolled or under controlled LDL cholesterol, an asymptomatic disease that "lurks" inside artery walls. "The Lipid Lurkers campaign was developed as a visual way to bring high LDL cholesterol to life and help patients understand and become better educated on the havoc that too much bad cholesterol is causing inside their artery walls," according to Eric Warren, CCO. "Of the multiple concepts tested, the Lipid Lurkers campaign was rated best among patients with high LDL-C on three key attributes: stopping power, impact, and motivation to ask their doctor about NEXLETOL and NEXLIZET." Esperion has adopted a "digital first" strategy enabling the company to gain the reach and frequency to generate increased awareness among the target audience. Digital channels, including search, direct, lifestyle, and programmatic display, social, and emails also allow the marketers to effectively measure what's working and where to optimize to achieve better growth within the key target audience. The Lipid Lurker characters will also be featured in point of care materials in HCP offices including waiting room videos and patient brochures. The campaign launched in April and initial results show that the campaign is reaching its target audience and having an impact. For the month of May 2024, the site recorded 190,000 clicks for more information generated from the campaign tactics.
|
DMRC | Hot Stocks08:04 EDT Digimarc appoints Katie Kool as chairperson - Digimarc announced the appointment of Katie Kool as the new chairperson of the company's board of directors, effective June 10. Kool succeeds Alicia Syrett, who has served as chairperson since 2020. Kool has served on the Digimarc Board of Directors since 2022.
|
GENE CHEOY | Hot Stocks08:04 EDT Genetic Technologies appoints Ziirsen as CFO, Company Secretary - Genetic Technologies (GENE) announces the appointment of Mark Ziirsen as Chief Financial Officer, CFO, and Company Secretary. Mark is a globally experienced ASX and Nasdaq listed CFO and company secretary with more than 25 years' experience operating across life sciences, technology and consumer segments that include senior finance leadership roles with major ASX listed companies including Cochlear (CHEOY).
|
AGNPF | Hot Stocks08:03 EDT Algernon Pharmaceuticals reports results of study on ifenprodil - Algernon Pharmaceuticals reports that ifenprodil achieved a 93% reduction in median cough count in an acute guinea pig citric acid challenge study. The multi-dose study was conducted under the direction of Seyltx, a private US-based drug development company which recently acquired Algernon's ifenprodil research program for the purchase price of $2M USD and a 20% equity position. The study was designed to inform dose selection in Seyltx's planned Phase 2b ifenprodil human study, recently named SILINDA, in refractory chronic cough. Seyltx has also announced that patient enrollment in the study is expected to begin in early 2025. Ifenprodil is an N-methyl-D-aspartate receptor antagonist specifically targeting the NR2B subunit, which prevents glutamate signalling. Ifenprodil represents a first-in-class potential treatment for chronic cough and interferes with central signalling in the brain, supressing the urge to cough. The near-complete suppression of cough was observed in animals receiving a dose of 30 mg/kg, in a dose-dependent manner, below the no observed adverse effect level dose. Other dosing arms included 1, 3, and 10 mg/kg. A clear and statistically significant dose response was observed. The full results of the study will be presented at the London International Cough Symposium July 18th - 19th, 2024. In an earlier Algernon Phase 2a clinical trial measuring cough in patients with idiopathic pulmonary fibrosis, ifenprodil, 20 mg TID, reduced cough by ~40% from baseline.
|
ANVS | Hot Stocks08:03 EDT Annovis receives FDA approval to transition to new crystal form of buntanetap - Annovis Bio announced that it has received approval from the U.S. Food and Drug Administration, FDA, to transition to a new solid form of buntanetap in future clinical trials. In June 2024, Annovis announced the filing of a composition of matter patent for the new crystal form of buntanetap and a provisional patent for the manufacturing process of this new form. The Company conducted comprehensive bridge studies in various solvents and in animals, comparing the old semi-crystalline form with the new crystalline form of buntanetap. The FDA has now approved the continuation of buntanetap's development using the new crystal form. This positive response allows Annovis to conduct a comparative study between the old and new forms of buntanetap in a small, single-dose, bioavailability study in humans as part of the transition process.
|
YOU | Hot Stocks08:02 EDT Clear Secure opens seven new locations. - Clear Secure continues to expand locations to enroll and renew consumers in the Trusted Traveler program by opening seven new locations. Clear now has 40 TSA PreCheck enrollment locations open across the U.S. The launch of the enrollment location at these seven airports represent the ongoing expansion of Clear's national TSA PreCheck enrollment footprint. Throughout 2024, Clear will continue delivering convenience to consumers by launching additional locations and extended hours of operation for enrollment and renewals. The seven new locations include: Boston Logan International Airport (BOS); John Glenn Columbus International Airport (CMH); Kansas City International Airport (MCI); Palm Beach International Airport (PBI); Cleveland Hopkins International Airport (CLE); Raleigh-Durham International Airport (RDU); Tulsa International Airport (TUL).
|
KMB | Hot Stocks08:02 EDT Kimberly-Clark names Craig Slavtcheff Chief Research and Development Officer - Kimberly-Clark has appointed Craig Slavtcheff as Chief Research and Development Officer, effective July 29. Slavtcheff will succeed Robert Long, who is retiring from the company after 45 years in the CPG industry, including the last three years at Kimberly-Clark. Slavtcheff most recently served as EVP, Chief R&D and Innovation Officer of Campbell Soup, where he led the R&D function, including strategy, product development, and corporate science and technology. Prior to that, he held senior roles at The Sun Products Corporation and Unilever. Slavtcheff will lead an R&D team of scientists focusing on proprietary, right to win spaces that build differentiated consumer preference and durable brand equity.
|
NEXCF AMZN | Hot Stocks07:43 EDT Nextech3D.AI selected as Amazon 3D model external content provider - Nextech3D.AI announces its certification as a Certified 3D Model External Content Provider for Amazon. Amazon listings with 3D models have seen a 2X improvement in purchase conversion on average according to a 2022 report from Amazon themselves. This high ROI is driving more sellers to adopt 3D models and now as a 3D Model External Content Provider for Amazon the company is strategically positioned in a significant growth opportunity.
|
MARIF | Hot Stocks07:41 EDT Marimaca Copper announces C$68M investment by Assore International Holdings - Marimaca Copper and Assore International Holdings announced a C$68 million equity investment by AIH in Marimaca. The Strategic Investment consists of the acquisition of 9,417,210 common shares of Marimaca by AIH from an affiliate of Tembo Capital Mining GP Limited, Ndovu Capital XIV B.V., at a price of C$4.50 per Common Share for gross proceeds to Tembo Capital of C$42,377,445 pursuant to a share purchase agreement dated July 15, 2024 and the issuance of 5,725,000 units of the Company to AIH by way of a non-brokered private placement for gross proceeds of C$25,762,500 pursuant to a subscription agreement dated July 15, 2024. Each Unit consists of one Common Share and one half of one Common Share purchase warrant at a price of C$4.50 per Unit. Each Warrant will entitle AIH to purchase one additional Common Share at an exercise price of C$5.85 for a period of 18 months following the closing of the AIH Private Placement. Following completion of the Strategic Investment and the Additional Private Placement, AIH will own approximately 14.99% of the issued and outstanding Common Shares on a non-diluted basis and 18.07% of the Common Shares on a partially diluted basis. Prior to the Tembo Acquisition and the AIH Private Placement, AIH did not own any securities of Marimaca. The Unit subscription price represents a 15% premium to the 20-day volume weighted average price of the Common Shares on the Toronto Stock Exchange as of July 12, 2024. In addition, another investor will subscribe for 1,000,000 Units by way of private placement on the same pricing terms as the AIH Private Placement for gross proceeds of C$4,500,000. Proceeds from the Private Placements will be used to advance the development of the Company's flagship Marimaca Copper Project located in the Antofagasta region, Chile and for exploration work programs at key targets within the Company's regional land package,
|
DNA | Hot Stocks07:40 EDT Ginkgo Bioworks, Syngenta Crop Protection enter pact for biological solution - Syngenta Crop Protection and Ginkgo Bioworks announced a new cooperation aimed at accelerating the launch of a new biological solution. The two companies have previously collaborated on next-generation seed technology. Through this new collaboration, Ginkgo plans to develop and optimize a microbial strain that can meet the productivity targets of a secondary metabolite from the Syngenta Biologicals pipeline. This molecule is earmarked by Syngenta as a pioneering biological solution.
|
EGO | Hot Stocks07:39 EDT Brixton Metals options Atlin Goldfields Project to Eldorado Gold - Brixton Metals entered into a definitive option agreement with Eldorado Gold Corporation, whereby Eldorado has been granted the option to acquire 100%-ownership of the Company's Atlin Goldfields Project. The Project is a road accessible, 579 square kilometer mineral claim group located near the town of Atlin, British Columbia and is located within the traditional territory of the Taku River Tlingit First Nation. Highlights of the Option Agreement: During the 5-year option period, Eldorado shall fund C$1,000,000 in exploration expenditures per year beginning September 30th, 2024, for an aggregate spend of C$5,350,000; including an additional minimum commitment to fund C$350,000 of exploration expenditures on or before September 30th, 2024; Eldorado shall make cash payments to Brixton of C$250,000 per year for aggregate payments of C$1,100,000 during the Option Period; including an additional minimum payment of C$100,000 within 10 days of signing the Option Agreement; In addition, at the end of the Option Period, Eldorado shall have the right to exercise the Option to acquire 100%-ownership of the Project by making a cash payment to Brixton in the amount of C$7,000,000; where Brixton, at its election, may receive up to 50% of such payment in the form of common shares of Eldorado, subject to the prior attainment of the customary requisite regulatory approvals; Eldorado may, in its sole discretion, elect at any time during the option period to accelerate the payments or funding timetables for any of the earn-in requirements of the Option; Upon exercise of the Option by Eldorado, Brixton shall be granted a 1.0% net smelter return royalty, with Eldorado retaining an option to purchase half of Brixton's NSR for C$2,000,000 prior to the commencement of commercial production at the Project; and During the Option Period, Brixton shall be the Operator of the Project with Eldorado approving all work programs and budgets relating to the Project. Eldorado will also work closely and support Brixton with respect to ongoing environmental monitoring and community engagement efforts.
|
STT | Hot Stocks07:39 EDT State Street reports Q2 ROE 11.9% vs. 13% last year - Reports NIM growth 6% vs. last year. Standardized common equity tier 1 ratio at quarter-end of 11.2% decreased 0.6% points compared to 2Q23.
|
RDW | Hot Stocks07:39 EDT Redwire gets follow on order for ROSA wings from Thales Alenia Space - Redwire announced it has secured a follow-on order to develop and deliver additional Roll-Out Solar Array or ROSA, wings for Thales Alenia Space's Space Inspire satellites, the company's newest product line of geostationary telecommunications satellites. A joint venture between Thales ...Thales Alenia Space is a leading prime manufacturer providing space solutions for telecommunications, Earth observation, exploration, and navigation. The follow-on order increases the total number of shipsets that Redwire will deliver based on its existing agreement with Thales Alenia Space. "Redwire is excited to further support Thales Alenia Space Inspire satellites, which are helping to connect the world via their ultra-flexible and robust capabilities. As a key supplier, we are focused on flawless execution and on-time delivery to ensure customer success," said Mike Gold, Redwire's Chief Growth Officer....development of Thales Alenia Space's Space Inspire product line is supported by the French national space agency CNES.
|
BDRBF | Hot Stocks07:38 EDT Bombardier completes installation of over 3,000 solar panels - Bombardier announced that more than 3,000 solar panels have been installed on the roof of Bombardier's London Biggin Hill Service Centre located at the London Biggin Hill Airport, underscoring its commitment to promote sustainable practices within the aviation industry and to reduce its energy consumption at its worldwide facilities. The recently completed project was developed in collaboration with Zestec Renewable Energy, a funder, developer and asset manager of renewable solutions and part of the Octopus Energy group. "At Bombardier, we are actively committed to ensuring that we are making aviation more sustainable and this includes the design and implementation of sustainability-related projects in our service facilities around the world," said Paul Sislian, Executive Vice President, Aftermarket Service & Strategy. "This recent installation is aligned with our company's objective to manufacture and service aircraft with the smallest possible environmental impact and demonstrates our company's commitment to lead the way to a greener industry."
|
PM | Hot Stocks07:38 EDT Philip Morris to invest $600M to open manufacturing facility in Colorado - Philip Morris announced an investment of $600M over the next two years through one of its U.S. affiliates to open a manufacturing facility in Aurora, Colorado. The facility is expected to create 500 direct jobs with ongoing annual economic impact of $550M and an additional 1,000 indirect jobs for the State of Colorado as it produces Swedish Match Zyn nicotine pouches. PMI's U.S. affiliate plans to break ground on the new facility later this year and to begin preliminary operations by the end of 2025 with regular production starting in 2026. The construction phase of the project alone is expected to create nearly 5,000 jobs related to the building of the facility with nearly $1B in economic impact.
|
MDWD | Hot Stocks07:37 EDT MediWound announces EUR 16.25M funding from EIC accelerator program - MediWound announced it has been selected to receive EUR 16.25 million in blended funding from the European Innovation Council, EIC, through its accelerator program. The funding will significantly advance the Company's EscharEx development program for patients with diabetic foot ulcers. Pending FDA and EMA approval, the funding will enable the Company to expedite the market introduction of this innovative biologic by four years, well ahead of MediWound's original schedule.
|
AMST | Hot Stocks07:36 EDT Amesite launches PREACTO app in beta - Amesite announced that the beta registration is now available for PREACTO, a proprietary app designed for personal safety and security. The new web app uses AI to provide helpful and easy-to-use tools for people who want to make their safety and security a priority, allowing them to proactively assess threats, plan safe routes and activities, update law enforcement, notify their circle of family and friends, and more.
|
INDO | Hot Stocks07:36 EDT Indonesia Energy completes recording of 3D seismic operations at Kruh Block - Indonesia Energy has completed the recording of 29 square kilometers of new 3D seismic at its 63,000 acre Kruh Block. IEC will now commence processing and detailed interpretation of the seismic data to optimize the selection of drilling locations in its Kruh, North Kruh and West Kruh fields. Importantly, IEC anticipates that the results of this seismic work may allow IEC to drill new production wells at Kruh Block by the end of 2024. Additionally, IEC announced that it expects to commence operations before the end of the year at its 650,000 acre Citarum Block where reserves could potentially exceed a billion barrels of oil equivalent. As the operator of the Kruh block, IEC's 3-D seismic program is strategically focused on existing proved reservoirs in the Talangakar and Lemat formations, as well as the very large and promising shallow oil/gas zones in the K-28 well discovered by IEC in 2022. The newly-acquired high quality three-dimensional seismic data will enable the identification of additional locations of proved undeveloped reserves and resources. This, in turn, will pave the way to prioritize the sequence of upcoming drilling locations as IEC recommences drilling operations at Kruh Block. Preparations for the new drilling operation are underway, with plans to drill the first well in the fourth quarter of 2024 after the evaluation of the new three-dimensional seismic data is completed. IEC announced in September 2023 that its joint operation contract with Pertamina, the Indonesian state-owned oil and gas company, covering the Kruh Block was extended by 5 years from May 2030 to September 2035. Kruh Block covers approximately 63,000 acres and is located onshore on the Island of South Sumatra in Indonesia. The amended joint operation contract has the following key terms: The amended contract increases IEC's after-tax profit split from the current 15% to 35%, for an increase of more than 100%. In addition, given the 5-year extended term of the contract, the amended contract is expected to increase IEC's proved reserves at Kruh Block by over 40%. Furthermore, given the increased profit split, IEC's anticipated net cash flow calculations based on its Kruh Block development plan are expected to increase by over 200% versus IEC's anticipations under the prior contract. At Citarum Block, IEC's recent receipt of government environmental permits paves the way to expeditiously commence seismic operations, with plans to commence drilling next year. As previously reported, IEC's estimates are that the Citarum Block has prospective oil-equivalent resources of over one billion barrels of oil.
|
CDT | Hot Stocks07:36 EDT Conduit Pharmaceuticals receives patent approval by IP Australia - Conduit Pharmaceuticals announced the approval of a composition of matter patent application by IP Australia, achieving successful examination of a patent on its lead asset, an HK-4 Glucokinase Activator which targets a wide range of autoimmune diseases. The Company is enrolled to participate in the Patent Prosecution Highway, a program to fast-track patent examination in major jurisdictions including the U.S., Europe and Japan. Since IP Australia has allowed patent application 2022384750, Conduit believes it is more likely to receive subsequent approvals in other markets. Patents in these major countries are the most sought after and valuable patents for marketed drug products, providing up to 20 years of patent protection.
|
ANRO | Hot Stocks07:35 EDT Alto Neuroscience completes enrollment in ALTO-100 study - Alto Neuroscience announced the completion of enrollment in its Phase 2b study of ALTO-100 in adults with major depressive disorder, or MDD. Topline results from this study are expected to be reported in October.
|
EVAX | Hot Stocks07:33 EDT Evaxion Biotech showcases improved performance of EvaxMHC - Evaxion Biotech A/S showcases improved performance of its key building block, EvaxMHC, within its AI-Immunology platform, at the 32nd Intelligent Systems for Molecular Biology, ISMB, conference taking place in Montreal, Canada, from July 12-16, 2024. Christian Kanstrup, Evaxion's CEO, comments: "Our results demonstrate significant improvements in the prediction of peptide-MHC interactions, particularly for MHC class II molecules, which have historically been difficult to predict accurately... The improved EvaxMHC building block is used in the ongoing Phase 2 trial with Evaxion's lead vaccine candidate, the personal cancer vaccine EVX-01." Key highlights showcased at the presentation: A state-of-the-art deep-learning framework was utilized, enhancing the accuracy of peptide-MHC predictions; Our approach includes three new strategies: Creating a unified representation for both MHC class I and -II molecules, utilizing a deep transformer encoder-decoder architecture, and adopting a generative adversarial network pretraining mechanism; The updated EvaxMHC building block led to improved vaccine designs demonstrated in preclinical studies.
|
ABXXF | Hot Stocks07:33 EDT Abaxx Exchange, Abaxx Clearing select Baymarkets Clara clearing system - Baymarkets and Abaxx Technologies announced that Abaxx's indirectly held, majority-owned Singapore-based exchange and clearinghouse, has chosen the award-winning Baymarkets clearing technology and platform, Clara, to power their newly-launched, Singapore-based Abaxx Commodity Futures Exchange and Clearinghouse, licensed as a Recognised Market Operator and Approved Clearing House with the Monetary Authority of Singapore. Abaxx Clearing is leveraging Baymarkets' clearing expertise and innovative technologies to support their initial suite of five new, centrally-cleared, physically-deliverable commodities futures contracts in liquefied natural gas and carbon, to be soon followed by solutions for battery metals and provide better price discovery and risk management tools for these transition-critical commodities Baymarkets' unique Clara clearing solution has been customized to meet the needs of the exchange, and Abaxx has the ability to further configure the system to fit specific commodities-market requirements, while also utilizing standard protocols and interfaces already integrated with multiple systems used by Abaxx clearing members, including Fidelity Information Services and ION.Abaxx selected Baymarkets, and its multi-asset, multi-currency Clara clearing system, for the ease and speed of service implementation, seamless integration with existing internal infrastructure, and considerable service flexibility.
|
STRM | Hot Stocks07:32 EDT Streamline Health expands RevID agreement with 400-bed children's health system - Streamline Health Solutions announced that it has expanded its contract for the use of RevID with a 425-bed, Oracle-EHR based health system and extended the term for an additional 5 years. "We are pleased with the continued trust our client places in our products and our team," stated Ben Stilwill, President and Chief Executive Officer, Streamline. "We look forward to supporting their quest to be accurately paid for all of the care they've provided and sharing their experience with future clients."
|
ANIK | Hot Stocks07:28 EDT Anika Therapeutics reports inducement grants under Nasdaq listing rule - Anika Therapeutics announced that on July 1, 2024, Anika granted non-statutory stock options covering an aggregate of 2,500 shares of common stock at a per share exercise price of $25.85, which equaled the closing price of common stock on the Nasdaq Global Select Market on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation. Of the shares covered by the Options, one-third will vest on each of the first three anniversaries of the grant date, in each case for so long as the grantee provides continuous service to Anika through the relevant vesting date. Unless earlier terminated in accordance with their terms, the Options will expire on the tenth anniversary of the grant date and are otherwise subject to the terms and conditions of the equity award agreement approved by Anika. The Options were granted pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, which was not subject to stockholder approval.
|
AY | Hot Stocks07:22 EDT Atlantica announces shareholder meetings to vote on acquisition by ECP - Atlantica Sustainable Infrastructure has published a scheme circular regarding the shareholder meetings to be held to consider and vote on the proposed acquisition of Atlantica by a private limited company incorporated in England and Wales. Bidco is controlled by Energy Capital Partners, a leading investor across energy transition, electrification and decarbonization infrastructure assets, and includes a large group of institutional co-investors. As set forth in the Scheme Circular, the Atlantica shareholder meetings for the Transaction will be held in London, UK on August 8, 2024. Algonquin Power & Utilities Corp. and Liberty, which hold approximately 42.2% of Atlantica's shares, have entered into a support agreement with Bidco pursuant to which Algonquin has agreed, subject to the terms of that agreement, to vote its shares in favor of the Transaction. The Atlantica Board of Directors unanimously recommends that Atlantica shareholders vote "FOR" each of the Transaction-related proposals at the shareholder meetings. Holders of record of Atlantica ordinary shares as of 6:30 p.m. on August 6, 2024 will be entitled to vote at the shareholder meetings. Atlantica shareholders are urged to read the Scheme Circular for more information, including how to vote at and, if applicable, attend the shareholder meetings.
|
DB | Hot Stocks07:21 EDT BaFin finds disclosure error in Deutsche Bank 2019 filing - German bank regulator BaFin has found that Deutsche Bank incorrectly disclosed deferred tax assets in its 2019 consolidated financial statement, it said on Tuesday. The bank did not disclose deferred tax assets of EUR 2.076B for its U.S. business separately in the notes to the financial statement, although it should have because it recorded losses over several years, BaFin said. "With this finding of an error, BaFin has concluded proceedings initiated by the German Financial Reporting Enforcement Panel." Reference Link
|
HHH MMP | Hot Stocks07:20 EDT Howard Hughes appoints Bhupesh Arora as CTO - Howard Hughes Holdings (HHH) announced that Bhupesh Arora has been named the company's Chief Technology Officer. Mr. Arora will oversee technology strategy, development, and operations across the company's national portfolio of large-scale master planned communities and mixed-use properties. He most recently served as the Vice President, Information Technology at Magellan Midstream Partners (MMP).
|
MTCH | Hot Stocks07:17 EDT Match Group holder Starboard Value sends letter to CEO/board on opportunity - Starboard Value which holds approximately 6.6% of the outstanding common shares of Match Group announced it sent a letter to the company's CEO & CFO, and Board of Directors regarding actionable opportunities for enhancing shareholder value. ...the letter lays out Starboard's view that Match should explore a sale in the event the company's leadership is unable to execute on the prescribed value-enhancing initiatives...The letter said in part: "As you know, Starboard Value is a large shareholder of Match Group... As disclosed in ourSchedule 13D filing... Match is a growing, high-quality business in a secularly growing industry and is deeply undervalued.... We believe Match has an opportunity to improve revenue growth from its expected 2024 growth rate of approximately 6%. In recent quarters, Match's revenue growth has been hindered by user and payer declines at Tinder, Match's largest app. We believe Tinder's issues are driven, in large part, by a lack of innovation at the product level after years of viral growth. We believe these and other issues at Tinder are addressable and resolving them will drive improved results...We believe Match can generate $5.50 or more of free cash flow per share in 2026. As shown below, Match is trading at less than 6.0x pro forma free cash flow, representing a greater than 60% discount to the companies shown below, despite having a similar growth profile. "
|
PNC | Hot Stocks07:14 EDT PNC Financial sees Q3 average loans stable vs. Q2 - Sees NII up 1%-2%; Fee income up 1%-2%; Other noninterest income $150M-$200M; Core noninterest expense up 3%-4%; Net charge offs $250M-$300M. All Q3 guidance vs. Q2. Comments taken from investor presentation slides for Q2 earnings conference call.
|
DNA | Hot Stocks07:09 EDT Ginkgo Bioworks and Syngenta to collaborate in new seed solution - Ginkgo Bioworks and Syngenta Crop Protection announced a new collaboration aimed at accelerating the launch of a new biological solution. The two companies have previously collaborated on next-generation seed technology. Through this new collaboration, Ginkgo plans to develop and optimize a microbial strain that can meet the productivity targets of a secondary metabolite from the Syngenta Biologicals pipeline. This molecule is earmarked by Syngenta as a pioneering biological solution. Successful cost-effective and large-scale production of this targeted metabolite would significantly expedite Syngenta's go-to-market timeline for its latest biological solution. To achieve this, Ginkgo will use its Ag Biologicals capabilities to calculate theoretical performance and guide rational strain engineering strategies to develop a microbial strain that is robust enough to meet Syngenta's goals.
|
GILT | Hot Stocks07:08 EDT Gilat Satellite awarded over $5M by National Defense Organization - Gilat Satellite Networks announced that a National Defense Organization awarded a multi-year contract for over $5M to one of the company's US-based subsidiaries, DataPath Inc. to upgrade their DKET terminals, transportable SATCOM network hubs. DataPath's multi-band tactical DKET terminals deliver the operational flexibility, capacity, connectivity, rapid deployability, and control required to support demanding communications in remote locations. DKET terminals deliver secure, reliable communications anywhere needed to establish network connectivity to support a mission with minimal manpower. "The upgrade of these terminals will provide this important National Defense Organization with continued dependable, high-performance connectivity," said Nicole Robinson, President of DataPath, Inc. "We understand the importance of their mission critical communications and are proud to be able to contribute to their success."
|
MICS | Hot Stocks07:07 EDT Singing Machine's SemiCab announces over $9M contracted revenue backlog - The Singing Machine Company announced it has successfully completed the acquisition of SemiCab, a leading artificial intelligence technology company in the global logistics space. Today, the Company provided an update on the integration process for the newly created operations under SemiCab Holdings. The Company currently has key executives in India, completing the final prerequisites for the acquisition of SMCB Solutions Private Limited, the wholly owned Indian subsidiary of SemiCab. SMCB has recently completed its annual audit as a small and medium enterprise under the Indian national regulatory regime. Concluding SMCB's audit, the Company is now currently underway to complete the acquisition of this subsidiary in the next 45 days. The Indian operations for SemiCab are expected to be the primary driver for near term revenue growth and new client acquisition. This subsidiary is expected to add approximately $1.35 million in last twelve months sales as of March 31, 2024. This subsidiary currently has in excess of $9 million in contracted services in the pipeline from existing client commitments. This sales backlog does not include incremental sales from two of SemiCab's largest customers, who are currently finalizing their increased renewal commitments, which are expected to add meaningfully to the $9 million backlog.
|
QUIK | Hot Stocks07:07 EDT QuickLogic expands distribution network with Spur Microwave - QuickLogic is pleased to announce a new distribution agreement with Spur Microwave. This partnership will significantly strengthen QuickLogic's presence and support for customers across the growing India market. Spur India is a prominent electronics distributor providing services and solutions for space, avionics, and other harsh environment applications where reliability is critical. They will now offer QuickLogic's innovative semiconductor products, including FPGAs and eFPGA Hard IP, throughout India. This collaboration ensures that customers in the region have direct access to QuickLogic's products, coupled with excellent service, to meet their demanding application needs.
|
OWL | Hot Stocks07:06 EDT Blue Owl Capital acquires Atalaya Capital Management's business for $450M - Blue Owl Capital has entered into a definitive agreement to acquire the business of alternative credit manager Atalaya Capital Management for $450M. The acquisition is expected to close in the second half of 2024, subject to customary closing conditions, and is expected to be modestly accretive to Blue Owl in 2025. Atalaya focuses primarily on asset-based credit investments across consumer and commercial finance, corporate and real estate assets, and managed over $10B of AUM as of June 30, 2024. Since inception, Atalaya has deployed over $17B of capital with nearly 70% of deal flow sourced directly through asset owners, originators or joint venture partners. Atalaya was founded in 2006 by Ivan Zinn, who serves as Founding Partner and Chief Investment Officer. Zinn will join Blue Owl as Head of Alternative Credit and will report to Craig Packer, Head of Credit and Co-President of Blue Owl. Atalaya is based in New York and has approximately 115 employees. Upon closing of the acquisition, most of Atalaya's employees are expected to join Blue Owl and will continue to manage existing Atalaya funds. The closing purchase price of $450M is comprised of $350M of Blue Owl equity and $100M of cash. In addition, there is potential for up to $350M of earnout consideration in the form of equity, subject to certain adjustments and achievement of future revenue targets.
|
JKS | Hot Stocks07:06 EDT JinkoSolar to form a joint venture with RELC and VI in Saudi Arabia - JinkoSolar announced that its indirectly majority-owned subsidiary, JinkoSolar Middle East DMCC, has entered into a shareholders agreement with Renewable Energy Localization Company, a wholly-owned subsidiary of Public Investment Fund and the national champion in the manufacturing of renewable and green energy technologies, and Vision Industries Company, a limited liability company incorporated in Saudi Arabia which is a leading investor and developer of green energy industrial projects and local supply chains. Pursuant to the Agreement, Jinko Middle East, RELC and VI agree to form a joint venture in Saudi Arabia with Jinko Middle East, RELC and VI holding 40%, 40% and 20% equity interest, respectively. The formation of the joint venture is subject to customary preconditions, including obtaining the requisite regulatory approvals. The joint venture will build and operate a high-efficiency solar cell and solar module manufacturing facility in Saudi Arabia. The manufacturing facility is expected to have a total investment amount of approximately $1B, and will be funded through a combination of its internal funds and external financing. The detailed production plan and schedule for the manufacturing facility will be subject to market conditions. Upon production, the manufacturing facility is expected to achieve an annual production capacity of 10 GW for each of high-efficiency solar cells and solar modules.
|
GOLD | Hot Stocks07:06 EDT Barrick Gold reports preliminary Q2 production of 948,000 oz. of gold - Barrick Gold reported preliminary Q2 production of 948 thousand ounces of gold and 43 thousand tonnes of copper, as well as preliminary Q2 sales of 956 thousand ounces of gold and 42 thousand tonnes of copper. As previously guided, Barrick's gold and copper production in 2024 is expected to progressively increase each quarter through the year with a higher weighting in the second half. The Company remains on track to achieve our full year gold and copper guidance. The average market price for gold in Q2 was $2,338 per ounce while the average market price for copper in Q2 was $4.42 per pound. Preliminary Q2 gold production was higher than Q1, as a result of increased production at Turquoise Ridge, following the completed maintenance at the Sage autoclave in Q1, continued successful ramp up at Porgera and significant increases at Tongon, North Mara and Kibali. These increases were partially offset by planned lower production at Cortez and Phoenix. Pueblo Viejo production was flat sequentially as throughput is ramped up with a shift to recovery rate optimization in H2 2024. Compared to Q1, Q2 gold cost of sales per ounce and total cash costs per ounce2 are both expected to be 0 to 2% higher. Absent the increase in the gold price in Q2, and consequential increase in royalties, total cash costs per ounce2 would have been lower compared to Q1. All-in sustaining costs per ounce are expected to be 1 to 3% higher. Costs are expected to drop in the second half of the year as production ramps up. Preliminary Q2 copper production was higher than Q1, driven primarily by higher grades and recoveries at Lumwana following the ramp up in stripping activities in Q1 as well as the planned shutdown in Q1. Compared to Q1 2024, Q2 copper cost of sales per pound1 is expected to be 4 to 6% lower, C1 cash costs per pound are expected to be 8 to 10% lower, while all-in sustaining costs per pound2 are expected to be 1 to 3% higher primarily due to increased waste stripping at Lumwana. Costs are expected to drop in the second half of the year as production ramps up.
|
ACIU | Hot Stocks07:06 EDT AC Immune announces three oral presentations at AAIC 2024 - AC Immune SA announced three oral presentations highlighting its precision medicine pipeline at the annual Alzheimer's Association International Conference, AAIC 2024, taking place in Philadelphia, PA, on July 28 - August 1, 2024. These posters include: Discovery and preclinical development of 18FACI-19626, a first-in-class TDP-43-PET tracer; Active immunotherapy, ACI-24.060, induces anti-Abeta antibodies with binding profiles mirroring clinically validated monoclonal antibodies; and A new class of neurodegenerative disease-fighting drugs: morADC.
|
GTEC | Hot Stocks07:04 EDT Greenland Technologies, Lonking announce strategic partnership - Greenland Technologies and Lonking Holdings announced a strategic partnership aimed at revolutionizing the heavy machinery industry in the United States. The collaboration will see the two companies combining their expertise to develop cutting-edge electric machinery under Greenland's popular HEVI brand, catering specifically to the needs of the U.S. market. This partnership brings together Greenland's extensive experience in electric vehicle technology and Lonking's leadership in heavy machinery manufacturing. By leveraging their respective strengths, the companies intend to introduce a new line of electric-powered heavy machinery that meets the demands for sustainability, efficiency, and performance in the U.S. construction and industrial sectors.
|
MTCH | Hot Stocks07:04 EDT Match Group holder Starboard Value sends letter to CEO/board on opportunity - Starboard Value which holds approximately 6.6% of the outstanding common shares of Match Group announced it sent a letter to the Company's Chief Executive Officer, President & Chief Financial Officer, and Board of Directors regarding actionable opportunities for enhancing shareholder value. In addition, the letter lays out Starboard's view that Match should explore a sale in the event the Company's leadership is unable to execute on the prescribed value-enhancing initiatives.
|
EYPT | Hot Stocks07:04 EDT EyePoint reports inducement grants under NASDAQ listing rule - EyePoint Pharmaceuticals announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 57,700 shares of EyePoint Pharmaceuticals common stock to nine new employees. The stock options were granted on July 15, 2024. The grants were approved by the Compensation Committee and made as an inducement material to each employee entering into employment with EyePoint Pharmaceuticals in accordance with NASDAQ Listing Rule 5635(c)(4). The option awards have an exercise price of $10.54 per share, the closing price of EyePoint Pharmaceuticals' common stock on July 15, 2024. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's date of grant and the remainder vesting in equal monthly installments over the following three years. Vesting of the options is subject to the employee's continued service with EyePoint Pharmaceuticals through the applicable vesting dates.
|
GNSS | Hot Stocks07:03 EDT Genasys announces LRAD, CONNECT synergies driving demand - Genasys announced that LRAD and CONNECT synergies are driving demand from law enforcement and public safety agencies as they prepare for the return of students to campuses, national elections, and civil unrest. "Civil disturbances pose unique challenges and elevated risks for police officers, communities, infrastructure, and the public," said Richard Danforth, CEO of Genasys. "These situations can quickly escalate, making timely and accurate communication essential. Law enforcement communications tools must provide real-time updates and enable coordinated responses to maintain public order and the safety of all concerned.
|
BTAI | Hot Stocks07:02 EDT BioXcel Therapeutics sees Q2 net revenues from sales of IGALMI of $1.1M - BioXcel Therapeutics announced preliminary estimated unaudited net revenue results from sales of IGALMI sublingual film for the second quarter ended June 30, 2024. The Company expects unaudited revenue of approximately $1.1M for the three months ended June 30, 2024, representing an increase of approximately 90% quarter over quarter and approximately 141% compared to the same period in 2023. Revenue growth was driven by an increase in contracting with psychiatric care clinics and behavioral health facilities using a small commercial team.
|
SNDL | Hot Stocks07:02 EDT Sundial Growers announces restructuring project, headcount reduction of 106 - SNDL announced a restructuring project aimed at reducing corporate overheads and improving the efficiency of its organizational structure to position the company for future growth. The project is expected to deliver over $20M in annualized cost savings driven primarily by the optimization of corporate overhead spending, including the reduction in 106 full-time employees. The restructuring will require a one-time investment of $11M over the next 18 months. As part of these operational adjustments, SNDL is consolidating its Cannabis segments into a single unit under the leadership of Tyler Robson. This consolidation is intended to enhance efficiency, improve alignment and improve process speed within SNDL's vertical model. "This restructuring project and segment consolidation are critical steps in our journey towards better capital deployment, improved agility, focus, and profitability, and will free up resources to invest in profitable growth opportunities," said Zachary George, Chief Executive Officer of SNDL. "We are committed to enhancing our organizational effectiveness by streamlining processes while leveraging technology and automation." SNDL expects to achieve most of the anticipated annualized savings by mid-2025, while starting to capture some of the opportunities as early as Q3 2024.
|
AVTX | Hot Stocks07:02 EDT Avalo Therapeutics appoints Doyle as Chief Medical Officer - Avalo Therapeutics announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical Officer. Dr. Doyle is a proven research physician who brings over 20 years of experience in the pharmaceutical/biotech industry and has held numerous leadership roles in clinical development. Dr. Doyle joins Avalo from Aro Biotherapeutics where she served as Chief Medical Officer since 2021.
|
OFIX RMD | Hot Stocks07:02 EDT Orthofix appoints Stephanie Walsh as chief human resources officer - Orthofix (OFIX) announced the appointment of Stephanie Walsh as chief human resources officer. Walsh joins Orthofix from ResMed (RMD), where she served most recently as VP of transformation.
|
PASG | Hot Stocks07:01 EDT Passage Bio received positive feedback in Type C meeting with FDA on PBFT02 - Passage Bio announced that the company received positive feedback in its Type C meeting process with the U.S. Food and Drug Administration, FDA, on its proposal to evaluate PBFT02 for treating frontotemporal dementia, FTD, patients with mutations in the C9orf72 gene. Compelling preclinical evidence, coupled with available safety and robust progranulin (PGRN) expression data from the first cohort of FTD-GRN patients treated with PBFT02, supported FDA alignment on the proposed trial expansion. The company intends to amend the protocol for the ongoing upliFT-D Phase 1/2 global study for FTD-GRN to introduce a new population of FTD-C9orf72 patients. The company plans to submit the revised trial protocol to health authorities and ethics committees promptly and expects to initiate dosing of FTD-C9orf72 patients in 1H 2025. The FDA has granted PBFT02 Fast Track and Orphan Drug designations. PBFT02 has also received an Orphan designation from the European Commission.
|
ASM | Hot Stocks06:57 EDT Avino Silver & Gold Mines reports Q2 production 616,571 silver equivalent ounces - Avino Silver & Gold Mines reported second quarter production of 616,571 silver equivalent ounces. Silver equivalent production increased 5% to 616,571 ounces. Silver production increased 26% to 292,946 ounces. Copper production decreased 10% to 1.3M pounds. Gold production was flat at 1,514 ounces. Mill throughput decreased by 10% to 140,934 tons.
|
PAG | Hot Stocks06:55 EDT Penske Automotive acquires Bill Brown Ford, terms undisclosed - Penske Automotive announced the acquisition of Bill Brown Ford in southeastern Michigan. Located in Livonia, the dealership operations serve Michigan's largest county by population. The acquisition is expected to add $550M in estimated annualized revenue. As part of the acquisition, the company will acquire over 200,000 square feet of existing facilities across 29 acres, including a main dealership premises, a pre-owned facility, a fleet maintenance center and a collision center.
|
ASXC | Hot Stocks06:52 EDT Asensus Surgical's Senhance Surgery System selected by Austrian hospital - Asensus Surgical announced that LKH-Universitatsklinikum Graz in Austria has entered into an agreement to lease and utilize a Senhance Surgical System. LKH-Universitatsklinikum Graz is a healthcare institution known for its expertise in minimally invasive pediatric and adolescent surgery. This hospital will be the 7th pediatric-focused site to utilize the Senhance Surgical System using 3mm and 5mm instruments for a variety of minimally invasive procedures.
|
SILO | Hot Stocks06:33 EDT Silo Pharma enters global license agreement for Alzheimer's drug SPC-14 - Silo Pharma announced that it has entered into an exclusive global license agreement to further develop, manufacture, and commercialize its Alzheimer's drug SPC-14. Silo intends to utilize the FDA's streamlined 505(b)(2) pathway for SPC-14, which would shorten clinical timelines and reduce drug development costs.
|
GIB | Hot Stocks06:31 EDT CGI awarded contract by city of Austin, Texas - CGI announced the award of a contract with the City of Austin, Texas, for an upgrade of the city's enterprise resource planning systems to the latest version of CGI Advantage, a cloud-based, built-for-government solution that integrates financial, vendor self-service, and procurement in a modern, unified platform. Continuing a long-term partnership with the city, CGI will introduce new features, including grants lifecycle management and other business processes that enable greater efficiency and cost savings for Austin's municipal government.
|
CMND SPRC | Hot Stocks06:06 EDT Clearmind Medicine submits US patent application for combination with SciSparc - Clearmind Medicine (CMND) has submitted an additional patent application with the USPTO, as part of its ongoing collaborations with SciSparc (SPRC) and with Prof. Joseph Tam from the Hebrew University's technology transfer company, Yissum. The patent application refers to the novel proprietary composition of Clearmind's MEAI compound with Palmitoylethanolamide, the active ingredient of SciSparc's proprietary CannAmide, for treating metabolic syndrome and obesity. Among adults aged 20 and over, the prevalence of obesity was 41.9%. The global obesity treatment market size was valued at $15B in 2022 and is expected to register a rapid revenue CAGR of 10.0% during the forecast period of 2023 to 2032. As part of the collaboration with SciSparc, twelve other patent applications have been filed by Clearmind with the USPTO for various proprietary compositions, including the composition of SciSparc's PEA with Clearmind's MEAI compound for the treatments of alcohol use disorder, cocaine addiction and obesity and its related metabolic disorders.
|
KBR | Hot Stocks06:04 EDT KBR to acquire LinQuest for $737M, sees accretion - KBR announced it has entered into a definitive agreement to acquire LinQuest Corporation. LinQuest is an engineering, data analytics and digital integration company. The transaction is expected to be accretive to adjusted EPS, which excludes amortization from purchased intangible assets and non-recurring transaction costs. The transaction has been unanimously approved by the KBR board of directors and is subject to certain regulatory approvals prior to closing. The purchase price is $737M, inclusive of modest expected tax benefits, which represents a FY25 adjusted EBITDA multiple of just over 11x. KBR will utilize a combination of cash and existing debt capacity to fund the transaction, which is expected to close in Q3 or Q4 this year.
|
KBR | Hot Stocks06:03 EDT KBR to Acquire LinQuest for $737M - KBR has entered into a definitive agreement to acquire LinQuest, an engineering, data analytics and digital integration company with a legacy of solving complex technical challenges for national security missions. They develop and integrate advanced technology solutions to meet demands across space, air dominance and connected battlespace missions, including advanced AI and machine learning capabilities. LinQuest supports the U.S. Space Force, U.S. Air Force and other U.S. Department of Defense and intelligence agencies. Over 74% of LinQuest's 1,500+ employees hold security clearances. The transaction is expected to be accretive to adjusted EPS, which excludes amortization from purchased intangible assets and non-recurring transaction costs. The transaction has been unanimously approved by the KBR Board of Directors and is subject to certain regulatory approvals prior to closing. The purchase price is $737M, inclusive of modest expected tax benefits, which represents a 2025 FY Adj. EBITDA multiple of just over 11x. KBR will utilize a combination of cash and existing debt capacity to fund the transaction, which is expected to close in Q3 or Q4 this year.
|
NKTX | Hot Stocks06:02 EDT Nkarta announces senior leadership changes - Nkarta announced changes to its leadership team. Nadir Mahmood, Ph.D., will join Nkarta as President this month, sharing executive leadership responsibilities with Paul Hastings, who continues in his role as CEO. Additionally, Nkarta has broadened the role of David Shook, M.D., to Chief Medical Officer, Head of Research & Development. Drs. Mahmood and Shook will both report to Hastings. The company expects to announce preliminary data from the Ntrust-1 and Ntrust-2 clinical trials data in 2025.
|
UNH | Hot Stocks06:00 EDT UnitedHealth provides update on cyberattack - The company said, "The company has restored the majority of the affected Change Healthcare services while continuing to provide financial support to the remaining health care providers in need. To date, the company has provided over $9 billion in advance funding and interest-free loans to support care providers. Total cyberattack impacts in the second quarter were $0.92 per share. This included $0.64 per share to support direct response efforts such as the Change Healthcare clearinghouse platform restoration and increased medical care expenditures. Additionally, Change Healthcare business disruption impacts, reflecting lost revenue and the costs of maintaining full readiness of the affected Change Healthcare services, were $0.28 per share in the second quarter. The company currently estimates the total full year 2024 impact at $1.90 to $2.05 per share. Within this, direct response costs are estimated at $1.30 to $1.35, an increase of $0.40 to $0.45 from the initial estimate. The change is due to the company's care provider financial support initiatives and consumer notification costs. Business disruption impacts are estimated at $0.60 to $0.70 per share."
|
AAPL... | Hot Stocks05:43 EDT UK watchdogs probe competitiveness of digital wallets from Apple, Google, PayPal - The U.K.'s Payments Systems Regulator and Financial Conduct Authority are probing the competitiveness of digital wallets from Apple (AAPL), Google (GOOGL), PayPal (PYPL), and others, and risks the wallets pose to consumers and businesses. "The use of digital wallets has grown rapidly over the last few years, and it's likely that more than half of UK adults now use one. With Apple Pay, Google Pay and PayPal being three of the most widely used digital wallets in the UK today, digital wallets have become an increasingly important touchpoint between big tech firms and UK consumers. The regulators are therefore keen to better understand the impact on consumers and businesses that digital wallets' increasing popularity creates, including: the range of benefits that digital wallets bring for service users whether there are any features that mean payments don't work as well as they could for consumers and/or businesses their role in unlocking the potential of account-to-account payments and how they could impact competition between payment systems; and whether digital wallets could raise any significant competition, consumer protection or market integrity issues, either now or in the future." The regulators said they will analyze all responses received and provide an update by Q1 2025. Reference Link
|
ZLAB ARGX | Hot Stocks05:34 EDT Zai Lab, Argenx announce China NMPA approval for efgartigimod alfa injection - Zai Lab (ZLAB) and Argenx (ARGX) announced that China's National Medical Products Administration, or NMPA, approved the biologics license application, or BLA, for efgartigimod alfa injection, 1,000mg/vial indicated as an add on to standard therapy for the treatment of adult patients with generalized myasthenia gravis, or gMG, who are anti-acetylcholine receptor, or AChR, antibody positive.
|
ALGT | Hot Stocks05:31 EDT Allegiant Travel announces eight new nonstop routes to 13 cities - Allegiant Travel announced eight new nonstop routes to 13 cities around the country. The company is offering one-way fares on the new routes as low as $39. The routes, launching in November, will provide air service to vacation destinations. These additional routes come at a time of high demand. With many travelers being mindful of their spending, Allegiant is committed to providing budget-friendly options that allow customers to enjoy their dream vacation without breaking the bank.
|
CTLT | Hot Stocks05:28 EDT Catalent completes $25M expansion of clinical supply facility in Germany - Catalent announced it has completed expansion of its clinical supply facility in Schorndorf, Germany. The Schorndorf site, Catalent's European facility, provides clinical supply services, including packaging, storage and distribution. The expansion increases the site's footprint by 32,000 square feet, adding storage and handling of clinical trial supply materials at controlled room temperatures between 15 and 25 degrees Celsius. It also creates space in the original building to accommodate the installation of a new, fully automatic bottle filling line, as well as a dedicated area for Catalent's FastChain demand-led supply service. These added capabilities will support a continued high level of service to Catalent's pharma and biotech customers and the patients they serve.
|
EGY | Hot Stocks05:27 EDT Vaalco Energy provides additional information regarding acquisition of Svenska - Vaalco Energy announced that it has filed a Form 8-K/A with the SEC that provides historical financial statements and additional reserves disclosures regarding its acquisition of Svenska Petroleum Exploration. As previously disclosed, Vaalco closed the acquisition of Svenska on April 30. Svenska's primary asset is a 27.39% non-operated working interest in the deepwater producing Baobab field in Block CI-40, offshore Cote d'Ivoire in West Africa. The net purchase price of $40.2M was fully funded by cash on hand with no issuance of debt or equity. At the time of initial announcement of the acquisition, Vaalco disclosed that the transaction included estimated 1P WI CPR reserves, as of October 1, 2023, of 13.0 MMBOE and total 2P WI CPR reserves at October 1, 2023, of 21.7M MMBOE; Vaalco at that time did not have a calculation of SEC proved reserves as of December 31, 2023 but has since worked with its third-party reserves auditors to calculate its SEC proved reserves and related Standardized Measure of Discounted Future Net Cash Flows as of that date utilizing a flat SEC pricing assumption of $83.06 per barrel of oil. In the SEC filing, Vaalco reported that SEC net proved reserves as of December 31, 2023 totaled 16.9 MMBOE. The Standardized Measure of those reserves as of December 31, 2023 totaled $107.1M. On a pro-forma basis, this results in Vaalco's year-end 2023 pro-forma SEC net proved reserves totaling 45.6 MMBOE, a 59% increase from its reported yearend 2023 SEC net proved reserves of 28.6 MMBOE. Utilizing the net cash purchase price of $40.2M, Vaalco paid approximately $2.37 per net proved barrel of reserves. 2P WI CPR reserves for Svenska as of December 31, 2023 are estimated at 22.5 MMBOE compared with the previously disclosed 21.7 MMBOE as of October 1, 2023. The discounted value of the future cash flows from those reserves as of December 31, 2023 totaled $240.9M. The pricing assumptions used in these CPR calculations was $79.79 per barrel of oil beginning in 2024, $69.79 in 2025, and inflating 2% thereafter. Vaalco notes that 2P reserves do not include significant upside from contingent resources at the Baobab field. Block CI-40 also includes the discovered but undeveloped Kossipo field, for which the company will update the contingent resources with its third-party reserves auditors in due course.
|
MASI | Hot Stocks05:21 EDT Masimo files commences litigation against Politan Capital Management - Masimo announced that it has commenced litigation against Politan Capital Management in federal court in California seeking to require Politan to correct material misstatements and omissions in Politan's proxy materials. The complaint alleges, among other things, that Quentin Koffey has assisted plaintiff's counsel in litigation against Masimo. Masimo has also set a new date for its 2024 annual meeting of stockholders and a new record date. The meeting is now scheduled for September 19. Masimo will also conduct a new broker search as required by rules of the Securities Exchange Commission. Accordingly, the new record date is August 12. Any votes previously submitted by Masimo stockholders in connection with the annual meeting will not be counted and previous proxies submitted will be disregarded, and therefore, all stockholders will need to resubmit their votes, even if they have previously voted.
|
BA | Hot Stocks05:18 EDT Emirates SkyCargo orders five more Boeing 777 freighters - Boeing and Emirates SkyCargo announced an order for five additional 777 Freighters as the operator again picks the world's most capable twin-engine freighter to meet growing cargo demand. The new purchase takes Emirates' order book to 245 Boeing widebody airplanes, including 10 777 Freighters. Emirates SkyCargo is the cargo division of Emirates, the world's largest international airline. Its investment in the 777 Freighter will boost main deck cargo capacity 30% by 2026. In all, Emirates' freighter fleet will grow to 17 airplanes - including 777 Freighters, 777 converted freighters and 747 Freighters.
|
LMND | Hot Stocks05:15 EDT Lemonade expands home insurance offering in the UK - Lemonade announced the launch of Buildings and Contents insurance in the United Kingdom. Expanding the company's home insurance offerings, homeowners throughout the UK can now purchase coverage for their home and belongings. Since launching in the UK in October 2022 and becoming a PRA-licensed carrier, the UK has quickly become one of Lemonade's fastest growing markets.
|
MBWM | Hot Stocks05:13 EDT Mercantile Bank increases regular cash dividend to 36c per share - Mercantile Bank announced that on July 11, its board of directors declared a regular quarterly cash dividend of 36c per common share, payable on September 18 to holders of record as of September 6. The 36c cash dividend represents increases of nearly 3% and 6% from the cash dividends paid during the second quarter of 2024 and third quarter of 2023, respectively.
|
KRKR | Hot Stocks05:07 EDT 36Kr Holdings enters strategic partnership with Zhi-Tech Group - 36Kr Holdings announced that it has entered into a strategic partnership with Zhi-Tech Group, a tech group focusing on the consumer industry, to broaden its business expansion and commercialization initiatives. 36Kr and Zhi-Tech will leverage their diverse strengths and resources to jointly explore commercialization and expansion opportunities in the consumer sector.
|